<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69314</article-id><article-id pub-id-type="doi">10.7554/eLife.69314</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Effect of SARS-CoV-2 proteins on vascular permeability</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-234064"><name><surname>Rauti</surname><given-names>Rossana</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8569-0810</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-234065"><name><surname>Shahoha</surname><given-names>Meishar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5947-484X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-234066"><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234067"><name><surname>Nasser</surname><given-names>Rami</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-195853"><name><surname>Paz</surname><given-names>Eyal</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234068"><name><surname>Tamir</surname><given-names>Rina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234069"><name><surname>Miller</surname><given-names>Victoria</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234070"><name><surname>Babich</surname><given-names>Tal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234071"><name><surname>Shaked</surname><given-names>Kfir</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234072"><name><surname>Ehrlich</surname><given-names>Avner</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234073"><name><surname>Ioannidis</surname><given-names>Konstantinos</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-111438"><name><surname>Nahmias</surname><given-names>Yaakov</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234074"><name><surname>Sharan</surname><given-names>Roded</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-171267"><name><surname>Ashery</surname><given-names>Uri</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6338-7888</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-167112"><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3823-7682</contrib-id><email>Bmaoz@tauex.tau.ac.il</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biomedical Engineering, Tel Aviv University</institution><addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line><country>Israel</country></aff><aff id="aff2"><label>2</label><institution>School of Neurobiology, Biochemistry and Biophysics, The George S. Wise Faculty of Life Sciences, Tel Aviv University</institution><addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line><country>Israel</country></aff><aff id="aff3"><label>3</label><institution>Sagol School of Neuroscience, Tel Aviv University</institution><addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line><country>Israel</country></aff><aff id="aff4"><label>4</label><institution>Blavatnik School of Computer Science, Tel Aviv University</institution><addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line><country>Israel</country></aff><aff id="aff5"><label>5</label><institution>Grass Center for Bioengineering, The Hebrew University of Jerusalem</institution><addr-line><named-content content-type="city">Jerusalem</named-content></addr-line><country>Israel</country></aff><aff id="aff6"><label>6</label><institution>The Center for Nanoscience and Nanotechnology, Tel Aviv University</institution><addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line><country>Israel</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mangoni</surname><given-names>Arduino A</given-names></name><role>Reviewing Editor</role><aff><institution>Flinders Medical Centre</institution><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barton</surname><given-names>Matthias</given-names></name><role>Senior Editor</role><aff><institution>University of Zurich</institution><country>Switzerland</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>25</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69314</elocation-id><history><date date-type="received" iso-8601-date="2021-04-12"><day>12</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-10-09"><day>09</day><month>10</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-03-01"><day>01</day><month>03</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.02.27.433186"/></event></pub-history><permissions><copyright-statement>© 2021, Rauti et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Rauti et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69314-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69314-figures-v1.pdf"/><abstract><p>Severe acute respiratory syndrome (SARS)-CoV-2 infection leads to severe disease associated with cytokine storm, vascular dysfunction, coagulation, and progressive lung damage. It affects several vital organs, seemingly through a pathological effect on endothelial cells. The SARS-CoV-2 genome encodes 29 proteins, whose contribution to the disease manifestations, and especially endothelial complications, is unknown. We cloned and expressed 26 of these proteins in human cells and characterized the endothelial response to overexpression of each, individually. Whereas most proteins induced significant changes in endothelial permeability, nsp2, nsp5_c145a (catalytic dead mutant of nsp5), and nsp7 also reduced CD31, and increased von Willebrand factor expression and IL-6, suggesting endothelial dysfunction. Using propagation-based analysis of a protein–protein interaction (PPI) network, we predicted the endothelial proteins affected by the viral proteins that potentially mediate these effects. We further applied our PPI model to identify the role of each SARS-CoV-2 protein in other tissues affected by coronavirus disease (COVID-19). While validating the PPI network model, we found that the tight junction (TJ) proteins cadherin-5, ZO-1, and β-catenin are affected by nsp2, nsp5_c145a, and nsp7 consistent with the model prediction. Overall, this work identifies the SARS-CoV-2 proteins that might be most detrimental in terms of endothelial dysfunction, thereby shedding light on vascular aspects of COVID-19.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>SARS-COV-2</kwd><kwd>vasculature</kwd><kwd>endothelium</kwd><kwd>protein interactions</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>2248/19</award-id><principal-award-recipient><name><surname>Rauti</surname><given-names>Rossana</given-names></name><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><name><surname>Tamir</surname><given-names>Rina</given-names></name><name><surname>Miller</surname><given-names>Victoria</given-names></name><name><surname>Babich</surname><given-names>Tal</given-names></name><name><surname>Shaked</surname><given-names>Kfir</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005155</institution-id><institution>Azrieli Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Rauti</surname><given-names>Rossana</given-names></name><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020</institution></institution-wrap></funding-source><award-id>SweetBrain 851765</award-id><principal-award-recipient><name><surname>Rauti</surname><given-names>Rossana</given-names></name><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Rauti</surname><given-names>Rossana</given-names></name><name><surname>Shahoha</surname><given-names>Meishar</given-names></name><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><name><surname>Paz</surname><given-names>Eyal</given-names></name><name><surname>Tamir</surname><given-names>Rina</given-names></name><name><surname>Miller</surname><given-names>Victoria</given-names></name><name><surname>Babich</surname><given-names>Tal</given-names></name><name><surname>Shaked</surname><given-names>Kfir</given-names></name><name><surname>Ashery</surname><given-names>Uri</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>207/10-1</award-id><principal-award-recipient><name><surname>Nasser</surname><given-names>Rami</given-names></name><name><surname>Ehrlich</surname><given-names>Avner</given-names></name><name><surname>Ioannidis</surname><given-names>Konstantinos</given-names></name><name><surname>Nahmias</surname><given-names>Yaakov</given-names></name><name><surname>Sharan</surname><given-names>Roded</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006259</institution-id><institution>Teva Pharmaceutical Industries</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>Zimin</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006245</institution-id><institution>Ministry of Science and Technology, Israel</institution></institution-wrap></funding-source><award-id>3-17351</award-id><principal-award-recipient><name><surname>Rauti</surname><given-names>Rossana</given-names></name><name><surname>Leichtmann-Bardoogo</surname><given-names>Yael</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>TCCP</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ashery</surname><given-names>Uri</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>953/16</award-id><principal-award-recipient><name><surname>Tamir</surname><given-names>Rina</given-names></name><name><surname>Miller</surname><given-names>Victoria</given-names></name><name><surname>Babich</surname><given-names>Tal</given-names></name><name><surname>Shaked</surname><given-names>Kfir</given-names></name><name><surname>Maoz</surname><given-names>Ben Meir</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A specific SARS-CoV-2 proteins that affect the vascular permeability and impairs the functionality of other significant organs has been identified.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Coronavirus disease (COVID-19) caused by the 2019 novel coronavirus (2019-nCoV/SARS-CoV-2) led to a global pandemic in 2020. By late September 2021, coronavirus had infected more than 220 million people worldwide, causing over 4.5 million deaths. After the initial phase of the viral infection, ~ 30% of patients hospitalized with COVID-19 develop severe disease with progressive lung damage, known as severe acute respiratory syndrome (SARS), and a severe immune response. Interestingly, additional pathologies have been observed, such as hypoxemia and cytokine storm which, in some cases, lead to heart and kidney failure, and neurological symptoms. Recent observations suggest that these pathologies are mainly due to increased coagulation and vascular dysfunction (<xref ref-type="bibr" rid="bib40">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="bib44">Libby and Lüscher, 2020</xref>; <xref ref-type="bibr" rid="bib70">Siddiqi et al., 2020</xref>). It is currently believed that in addition to being a respiratory disease, COVID-19 might also be a ‘vascular disease’ (<xref ref-type="bibr" rid="bib40">Lee et al., 2021</xref>), as it may result in a leaky vascular barrier and increased expression of von Willebrand factor (VWF) (<xref ref-type="bibr" rid="bib70">Siddiqi et al., 2020</xref>), responsible for increased coagulation, cytokine release, and inflammation (<xref ref-type="bibr" rid="bib70">Siddiqi et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Teuwen et al., 2020</xref>; <xref ref-type="bibr" rid="bib2">Aid et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Potus et al., 2020</xref>; <xref ref-type="bibr" rid="bib79">Wazny et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Pum et al., 2021</xref>; <xref ref-type="bibr" rid="bib7">Barbosa et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Lin et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Matarese et al., 2020</xref>; <xref ref-type="bibr" rid="bib84">Xiao et al., 2020</xref>). Recent studies suggest that the main mechanism disrupting the endothelial barrier occurs in several stages: First, a direct effect on the endothelial cells that causes an immune response of the vascular endothelium (endotheliitis) and endothelial dysfunction. Second, lysis and death of the endothelial cells <xref ref-type="bibr" rid="bib72">Teuwen et al., 2020</xref>; <xref ref-type="bibr" rid="bib84">Xiao et al., 2020</xref> followed by sequestering of human angiotensin I-converting enzyme 2 (hACE2) by viral spike proteins that activate the kallikrein–bradykinin and renin–angiotensin pathways, increasing vascular permeability (<xref ref-type="bibr" rid="bib72">Teuwen et al., 2020</xref>; <xref ref-type="bibr" rid="bib74">Varga et al., 2020</xref>). Last, overreaction of the immune system, during which a combination of neutrophils and immune cells producing reactive oxygen species, inflammatory cytokines (e.g., interleukin [IL]-1β, IL-6, and tumor necrosis factor), and vasoactive molecules (e.g., thrombin, histamine, thromboxane A2, and vascular endothelial growth factor), and the deposition of hyaluronic acid lead to disruption of endothelial junctions, increased vascular permeability, and leakage and coagulation (<xref ref-type="bibr" rid="bib44">Libby and Lüscher, 2020</xref>; <xref ref-type="bibr" rid="bib72">Teuwen et al., 2020</xref>; <xref ref-type="bibr" rid="bib74">Varga et al., 2020</xref>). Of great interest is the effect on the brain’s vascular system. Cerebrovascular effects have been suggested to be among the long-lasting effects of COVID-19. Indeed, the susceptibility of brain endothelial cells to direct SARS-CoV-2 infection was found to increase due to increased expression of hACE2 in a blood flow-dependent manner, leading to a unique gene expression process that might contribute to the cerebrovascular effects of the virus (<xref ref-type="bibr" rid="bib60">Pober and Sessa, 2007</xref>).</p><p>While many studies point out the importance of the vascular system in COVID-19 (<xref ref-type="bibr" rid="bib32">Kaneko et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Jung et al., 2020b</xref>; <xref ref-type="bibr" rid="bib51">Nägele et al., 2020</xref>), only a few <xref ref-type="bibr" rid="bib62">Pons et al., 2020</xref>; <xref ref-type="bibr" rid="bib13">Chioh et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">Nascimento Conde et al., 2020</xref>; <xref ref-type="bibr" rid="bib9">Buzhdygan et al., 2020</xref> have looked at the direct vascular response to the virus. Most of those reports stem from either clinical observations, or in vitro studies or in vivo studies in which animals/cells were transfected with the SARS-CoV-2 virus and their systemic cellular response assessed, without pinpointing the specific viral protein(s) causing the observed changes. SARS-CoV-2 is an enveloped virus with a positive-sense, single-stranded RNA genome of ∼30 kb, encoding 29 proteins (<xref ref-type="fig" rid="fig1">Figure 1</xref>). These proteins can be classified as: <italic>structural proteins</italic>: S (spike proteins), E (envelope proteins), M (membrane proteins), N (nucleocapsid protein and viral RNA); <italic>nonstructural proteins</italic>: nsp1–16; <italic>open reading frame accessory proteins</italic>: orf3–10 (<xref ref-type="bibr" rid="bib36">Kim et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Hu et al., 2021</xref>). <xref ref-type="table" rid="table1">Table 1</xref> summarizes the known effects of specific SARS-CoV-2 proteins (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>; <xref ref-type="bibr" rid="bib64">Procko, 2020</xref>; <xref ref-type="bibr" rid="bib14">Cornillez-Ty et al., 2009</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Hillen et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>). The functionality of some of these is still unknown. Moreover, a considerable knowledge gap still exists regarding molecular mechanisms, especially the protein–protein interaction (PPI) pathways (<xref ref-type="bibr" rid="bib15">Cowen et al., 2017</xref>), leading to tissue dysfunction.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Effect of severe acute respiratory syndrome (SARS)-CoV-2 proteins on endothelial cells.</title><p>(a) Sketch representing the main organs affected by SARS-CoV-2; (<bold>b</bold>) structure and gene composition of SARS-CoV-2.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig1-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Severe acute respiratory syndrome (SARS)-CoV-2 proteins.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">SARS-CoV-2 proteins</th><th align="left" valign="bottom">General impact</th></tr></thead><tbody><tr><td align="left" colspan="2" valign="bottom"> <bold>Structural proteins</bold></td></tr><tr><td align="left" valign="bottom"><bold>S (spike</bold>)</td><td align="left" valign="bottom">Spike protein, mediates binding to ACE2, fusion with host membrane<break/>Surface glycoprotein, needs to be processed by cellular protease TMPRSS2 (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>M (membrane</bold>)</td><td align="left" valign="bottom">Membrane glycoprotein, the predominant component of the envelope<break/>A major driver for virus assembly and budding (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>E (envelope</bold>)</td><td align="left" valign="bottom">Envelope protein, involved in virus morphogenesis and assembly<break/>Coexpression of M and E is sufficient for virus-like particle formation and release (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>N (nucleocapsid</bold>)</td><td align="left" valign="bottom">Nucleocapsid phosphoprotein binds to RNA genome (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" colspan="2" valign="bottom"><bold>Nonstructural proteins</bold></td></tr><tr><td align="left" valign="bottom"><bold>nsp1</bold></td><td align="left" valign="bottom">Leader sequence, suppresses host antiviral response<break/>Antagonizes interferon induction to suppress host antiviral response (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp2</bold></td><td align="left" valign="bottom">Interferes with host cell signaling, including cell cycle, cell-death pathways, and cell differentiation<break/>May serve as an adaptor for nsp3<break/>Not essential for virus replication, but deletion of nsp2 diminishes viral growth and RNA synthesis (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Procko, 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp3</bold></td><td align="left" valign="bottom">nsp3–nsp4–nsp6 complex involved in viral replication<break/>Functions as papain-like protease (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp4</bold></td><td align="left" valign="bottom">nsp3–nsp4–nsp6 complex involved in viral replication (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)<break/>The complex is predicted to nucleate and anchor viral replication complexes on double-membrane vesicles in the cytoplasm (mitochondria)</td></tr><tr><td align="left" valign="bottom"><bold>nsp5</bold></td><td align="left" valign="bottom">Inhibits interferon I signaling processes by intervening in the NF-κB process and breaking down STAT one transcription factor<break/>Functions as 3-chymotrypsin-like protease, cleaves the viral polyprotein (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp5_c145a</bold></td><td align="left" valign="bottom">Catalytic dead mutant of nsp5 (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp6</bold></td><td align="left" valign="bottom">nsp3–nsp4–nsp6 complex involved in viral replication<break/>Limits autophagosome expansion<break/>Components of the mitochondrial complex V (the complex regenerates ATP from ADP) copurify with nsp6 (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp7</bold></td><td align="left" valign="bottom">Cofactor of nsp12<break/>nsp7–nsp8 complex in part of RNA polymerase (nsp7, 8, 12 – replication complex)Affects electron transport, GPCR signaling, and membrane trafficking (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Hillen et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp8</bold></td><td align="left" valign="bottom">Cofactor of nsp12<break/>nsp7–nsp8 complex in part of RNA polymerase. Affects the signal recognition particle and mitochondrial ribosome (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp9</bold></td><td align="left" valign="bottom">ssRNA binding protein (can bind both DNA and RNA, but prefers ssRNA)<break/>Interacts with the replication complex (nsp7, 8, 12) (<xref ref-type="bibr" rid="bib14">Cornillez-Ty et al., 2009</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp10</bold></td><td align="left" valign="bottom">Cofactor of nsp16 and nsp14 (<xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>)<break/>Essential for nsp16 methyltransferase activity (stimulator of nsp16)<break/>Zinc finger protein essential for replication (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp11</bold></td><td align="left" valign="bottom">Unknown function</td></tr><tr><td align="left" valign="bottom"><bold>nsp12</bold></td><td align="left" valign="bottom">Functions as an RNA-direct RNA polymerase, the catalytic subunitAffects the spliceosome (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Hillen et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp13</bold></td><td align="left" valign="bottom">Has helicase and 5’ triphosphatase activity<break/>Initiates the first step in viral mRNA capping nsp13,14,16 installs the cap structure onto viral mRNA in the cytoplasm instead of in the nucleus, where the host mRNA is capped (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Ivanov et al., 2004</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp14</bold></td><td align="left" valign="bottom">In addition to the capping function of the methyltransferase, nsp14 is also an endonuclease (3’–5’ exoribonuclease) that corrects mutations during genome replication (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp15</bold></td><td align="left" valign="bottom">Endoribonuclease has uridine-specific endonuclease activity, essential for viral RNA synthesis (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom"><bold>nsp16</bold></td><td align="left" valign="bottom">May involve complexation with nsp10 and nsp14, for stabilization of homoenzyme, for capping the mRNA (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>; <xref ref-type="bibr" rid="bib67">Romano et al., 2020</xref>)</td></tr><tr><td align="left" colspan="2" valign="bottom"><bold>Open reading frame (accessory factors</bold>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf3a</bold></td><td align="left" valign="bottom">Packaging into virions<break/>Mediates trafficking of spike protein by providing ER/golgi retention signals<break/>Induces IL-6b, activates NF-κB, activates the NLRP3 inflammasome (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf3b</bold></td><td align="left" valign="bottom">Interferon antagonist and involved in pathogenesis (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf6</bold></td><td align="left" valign="bottom">Type I interferon antagonist, suppresses the induction of interferon, and interferon signaling pathways (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf7a</bold></td><td align="left" valign="bottom">May be related to viral-induced apoptosis (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf7b</bold></td><td align="left" valign="bottom">Unknown function</td></tr><tr><td align="left" valign="bottom">o<bold>rf8</bold></td><td align="left" valign="bottom">Recombination hotspot<break/>Induces ER stress and activates NLRP3 inflammasomes<break/>Low similarity to SAR-CoV (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf9b</bold></td><td align="left" valign="bottom">Suppresses host antiviral response<break/>Targets the mitochondrion-associated adaptor molecules MAVS and limits host cell interferon responses (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf9c</bold></td><td align="left" valign="bottom">No evidence that this protein is expressed during SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr><tr><td align="left" valign="bottom">o<bold>rf10</bold></td><td align="left" valign="bottom">No evidence that this protein is expressed during SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib25">Gordon et al., 2020</xref>)</td></tr></tbody></table></table-wrap><p>To tackle these challenges, we cultured human umbilical vein endothelial cells (HUVECs) and systematically transduced them with lentiviral particles encoding 26 out of the 29 viral proteins, separately. The three remaining genes were not included in this study purely for technical reasons. We then examined their effects on HUVEC monolayer permeability and the expression of factors involved in vascular permeability and coagulation. The results were analyzed in the context of virus–host and host–host PPI networks. By combining the insights from the experimental and computational results, we generated a model that explains how each of the 26 proteins of SARS-CoV-2, including a mutated form of nsp5, the catalytic dead mutant termed nsp5_c145a, affects the protein network regulating vascular functionality. Moreover, once the PPI model was validated with our experimental data, we applied it to more than 250 proteins that have been identified in the literature as affected by the SARS-CoV-2 proteins. This enabled us to pinpoint the more dominant SARS-CoV-2 proteins and chart their effects. Overall, this work shows how each of the SARS-CoV-2 proteins differentially affects vascular functionality; moreover, once the model was validated, we applied it to identify how SARS-CoV-2 proteins interact with proteins that have been significantly correlated with changes in cell functionality.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>SARS-CoV-2 proteins impair barrier properties affecting cell-junction proteins</title><p>Increasing numbers of studies indicate a significant role for the vasculature in the physiological response to SARS-CoV-2. However, neither the exact molecular mechanism that leads to these effects nor the individual contribution of any of the SARS-CoV-2 proteins is known. Plasmids encoding SARS-CoV-2 proteins were cloned into lentivirus vectors, with eGFP-encoding vector used as a negative control. To shed light on the vascular response to the virus, HUVECs were cultured on different platforms, transduced with these lentiviral particles, and assessed for the effects of the virus proteins on different functionalities. Culturing HUVEC on Transwells or glass coverslips (<xref ref-type="fig" rid="fig2">Figure 2a</xref>) allowed us to identify how the specific proteins affect endothelial functionality. To ensure proper infection, the control vector included a GFP label, which enabled us to estimate infection efficiency at around 70 % (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). Since the most basic function of the endothelium is to serve as a barrier, we sought to identify the changes in endothelium permeability in response to the SARS-CoV-2 proteins, and to pinpoint which of these proteins have the most significant effect. Barrier functions and properties were measured via trans-epithelial-endothelial electrical resistance (TEER), a standard method that identifies changes in impedance values, reflecting the integrity and permeability of the cell monolayer (<xref ref-type="bibr" rid="bib71">Srinivasan et al., 2015</xref>). The GFP control and nine SARS-CoV-2 proteins did not show any significant change in TEER values (compared to the untreated condition), whereas 18 of the SARS-CoV-2 proteins caused significant changes in value (see plot in <xref ref-type="fig" rid="fig2">Figure 2b</xref>). The most dominant permeability changes were observed with nsp5_c145a, nsp13, nsp7, orf7a, and nsp2, with a 20–28% decrease in TEER values (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, and <xref ref-type="fig" rid="fig2">Figure 2c</xref>), in which the different SARS-CoV-2 proteins are listed and the gradual color change from red to violet represents the progressive reduction in TEER values. <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> shows the comparison in TEER values before the infection and 3 and 4 days after the infection, showing that the permeability changes in the cells exposed to the viral proteins are maintained.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Effect of severe acute respiratory syndrome (SARS)-CoV-2 proteins on human umbilical vein endothelial cell (HUVEC) at day 3.</title><p>(a) Bright-field and fluorescent image of infected eGFP HUVEC, scale bar: 50 µm; (<bold>b</bold>) changes in barrier functions as a result of SARS-CoV-2 proteins were assessed by trans-epithelial-endothelial electrical resistance (TEER) measurement. Note the statistical differences compared to the untreated control condition, assessed by F-statistic with two-way ANOVA test, followed by the Holm–Sidak test for multiple comparisons; (<bold>c</bold>) color map showing a gradual decrease in TEER values compared to the untreated condition at day 3; (<bold>d</bold>) immunocytochemistry (ICC) for CD31 (green) and Hoechst (blue) for the three specified conditions, scale bar: 20 µm; (<bold>e</bold>) analysis of CD31 expression levels.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Effect of severe acute respiratory syndrome (SARS)-CoV-2 proteins on human umbilical vein endothelial cell (HUVEC) functionality.</title><p>Trans-epithelial-endothelial electrical resistance (TEER) values at three different time points: before the infection (blue dots), 3 and 4 days after the infections (pink and green dots).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Next, we analyzed some of the proteins that exhibited the most significant (nsp2, nsp5_c145a, and nsp7) or least significant (S) changes in TEER value for changes in expression of the cell-junction proteins such as CD31 (<xref ref-type="fig" rid="fig2">Figure 2d and e</xref>), cadherin 1–5, occludin, and ZO 1–3 (presented later), indicating altered barrier functions. Analysis of the immunocytochemistry (ICC) (<xref ref-type="fig" rid="fig2">Figure 2d and e</xref>) showed, as expected, that nsp2, nsp5_c145a, and nsp7 significantly reduce the expression levels of CD31 compared to the untreated, eGFP, and S conditions, suggesting a deterioration in barrier function. Hence, these data show a differential effect of SARS-CoV-2 proteins on endothelial functionality and provide a mechanistic explanation for the reduction in endothelial integrity.</p></sec><sec id="s2-2"><title>Increased endothelial inflammatory response caused by SARS-CoV-2 proteins</title><p>It is known that SARS-CoV-2 can cause a severe cytokine storm (<xref ref-type="bibr" rid="bib65">Pum et al., 2021</xref>; <xref ref-type="bibr" rid="bib77">Wang et al., 2020a</xref>) and a significant increase in coagulation-related pathologies. As we were interested in identifying the role of the vasculature in these observations, we stained and analyzed the expression level of VWF (<xref ref-type="fig" rid="fig3">Figure 3a and b</xref>), which is highly correlated with coagulation (<xref ref-type="bibr" rid="bib66">Rietveld et al., 2019</xref>). Similar to the CD31 staining, we characterized only those proteins that resulted in a significant decrease in TEER values (nsp2, nsp5_c145a, and nsp7). As shown in <xref ref-type="fig" rid="fig3">Figure 3a and b</xref>, the control samples did not exhibit marked expression of VWF, whereas the cells transfected with nsp2, nsp5_c145a, and nsp7 showed a significant change in VWF expression. Moreover, as VWF is also associated with increased inflammation (<xref ref-type="bibr" rid="bib34">Kawecki et al., 2017</xref>), we monitored changes in cytokine expression due to the different SARS-CoV-2 proteins (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). We were particularly interested in IL-6, which has been identified as one of the most dominant cytokines expressed due to SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib77">Wang et al., 2020a</xref>; <xref ref-type="bibr" rid="bib3">Akbari and Rezaie, 2020</xref>; <xref ref-type="bibr" rid="bib58">Peruzzi et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Liao et al., 2020b</xref>; <xref ref-type="bibr" rid="bib42">Liao et al., 2020a</xref>). We observed that 13 out of the 26 proteins caused an increase in IL-6 secretion, 3 of which had resulted in a decrease in barrier function and increased VWF expression.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Human umbilical vein endothelial cell (HUVEC) response to specific proteins.</title><p>(a) Confocal reconstructions of HUVEC stained for von Willebrand factor (VWF) (green) and Hoechst (blue) for three conditions: control (untreated), eGFP, and nsp5_c145a, scale bar: 20 µm; (<bold>b</bold>) analysis of VWF expression levels; (<bold>c</bold>) fold change of interleukin (IL)-6 in response to the different proteins.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig3-v1.tif"/></fig></sec><sec id="s2-3"><title>Correlation between vascular permeability impairment and viral proteins</title><p>We then investigated how SARS-CoV-2 causes the observed changes in HUVECs permeability. We collected sets of proteins responsible for specific functionalities of endothelial cells. We also constructed an integrated viral–host and host–host PPI network. For each viral protein and each prior functional set, we measured the network proximity between the viral protein and the human functional set using a network propagation algorithm. We scored the significance of these propagation calculations by comparing them to those obtained on random PPI networks with the same node degrees. Proteins receiving high and significant scores were most likely to interact with the specific SARS-CoV-2 protein and thus might cause the observed functional changes. When comparing the overall effects of the 26 SARS-CoV-2 proteins on endothelial TJ proteins (e.g., cadherin 1–5, occludin, and ZO 1–3), we found a correlation between the effects of the SARS-CoV-2 proteins and TEER values (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Moreover, some of the proteins that significantly affected the TEER parameters (<xref ref-type="fig" rid="fig2">Figure 2c</xref>) were also observed to be significantly proximal to the permeability-related set. These included nsp2, nsp7, and nsp13 (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Our algorithm identified cadherin-2, α-catenin, β-catenin, δ-catenin, and ZO 1 and 2 as the most susceptible proteins to SARS-CoV-2 infection (<xref ref-type="fig" rid="fig4">Figure 4b</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Correlation between viral protein effect on permeability and proximity to permeability-related proteins in a protein–protein interaction (PPI) network.</title><p>(a) Correlation of adjusted p-value versus permeability (Pearson = 0.295); (<bold>b</bold>) proximity between vascular proteins and the viral proteins.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig4-v1.tif"/></fig><p>To validate our PPI network model, we performed immunostaining of some TJ proteins (β-catenin, cadherin-5, ZO-1, and occludin) of HUVEC transfected with viral proteins and to compare it to the model prediction. Similar to the CD31 staining, we characterized only those proteins that significantly decreased TEER values (nsp2, nsp5_c145a, and nsp7) compared to the eGFP and untreated condition (<xref ref-type="fig" rid="fig5">Figure 5</xref>). As shown in <xref ref-type="fig" rid="fig5">Figure 5a–c</xref>, the cells transfected with nsp2, nsp5_c145a, and nsp7 showed a significant reduction in the β-catenin, cadherin-5, and ZO-1 intensity, confirming the ability of the SARS-CoV-2 proteins to impair endothelial permeability.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Tight-junctions impairment by severe acute respiratory syndrome (SARS)-CoV-2 proteins.</title><p>Immunocytochemistry (ICC) for (a) β-catenin (green), (b) cadherin-5 (green), (<bold>c</bold>) ZO-1 (green), (<bold>d</bold>) occludin (green), and Hoechst (blue) for five specified conditions: untreated, eGFP, nsp2, nsp5-c1451, and nsp7. Relative quantification is shown for each tight junction (TJ) protein for all five conditions on the right. Scale bar: 50 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig5-v1.tif"/></fig><p>Once the model was validated, we used it to identify how the individual SARS-Cov-2 proteins affect nine other different vascular endothelial cells. As a starting point, we created a table (<xref ref-type="table" rid="table2">Table 2</xref>) (based on the literature) where we compared the expression of 12 different TJ proteins across nine different types of endothelial cells. We then applied the network-based model to identify which endothelial cells are more susceptible to the different SARS-Cov-2 proteins. As can be seen in <xref ref-type="fig" rid="fig6">Figure 6</xref>, there are significant differences in the response of various viral proteins on different types of vascular endothelial cells. For example,, the viral proteins nsp13, nsp11, orf6, and S seem to have a significant effect on the different types of vascular endothelial cells, according to the network score detected. However, the proteins m, E, n, nsp12, and nsp8 are the less interactive with the vascular cells.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Comparison of tight junction (TJ) proteins expression among different types of vascular endothelial cells.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Endothelial cells type</th><th align="left" colspan="12" valign="bottom">TJ proteins</th></tr></thead><tbody><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom"><bold>Cadherin-2</bold></td><td align="left" valign="bottom"><bold>Cadherin-3</bold></td><td align="left" valign="bottom"><bold>Cadherin-4</bold></td><td align="left" valign="bottom"><bold>Cadherin-5</bold></td><td align="left" valign="bottom"><bold>δ-1-Catenin</bold></td><td align="left" valign="bottom"><bold>β-Catenin</bold></td><td align="left" valign="bottom"><bold>α-Catenin</bold></td><td align="left" valign="bottom"><bold>Occludin</bold></td><td align="left" valign="bottom"><bold>Claudin-5</bold></td><td align="left" valign="bottom"><bold>ZO-1</bold></td><td align="left" valign="bottom"><bold>ZO-2</bold></td><td align="left" valign="bottom"><bold>ZO-3</bold></td></tr><tr><td align="left" valign="bottom">Human pulmonary artery endothelial cells (HPAECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib29">Ivanov et al., 2004</xref>; <xref ref-type="bibr" rid="bib24">Ferreri et al., 2008</xref>; <xref ref-type="bibr" rid="bib22">DiStefano et al., 2014</xref>; <xref ref-type="bibr" rid="bib87">Zebda et al., 2013</xref>; <xref ref-type="bibr" rid="bib86">Yuan et al., 2012</xref>; <xref ref-type="bibr" rid="bib76">Wang et al., 2011</xref>)</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td></tr><tr><td align="left" valign="bottom">Human umbilical vein endothelial cells (HUVECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib24">Ferreri et al., 2008</xref>; <xref ref-type="bibr" rid="bib82">Wu et al., 2008</xref>; <xref ref-type="bibr" rid="bib18">Dean et al., 2009</xref>; <xref ref-type="bibr" rid="bib61">Polus et al., 2006</xref>; <xref ref-type="bibr" rid="bib19">DeBusk et al., 2010</xref>; <xref ref-type="bibr" rid="bib80">Wessells et al., 2009</xref>)</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td></tr><tr><td align="left" valign="bottom">Human umbilical artery endothelial cells (HUAECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib17">Davis et al., 2003</xref>; <xref ref-type="bibr" rid="bib28">Ikuno et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Kevil et al., 1998</xref>; <xref ref-type="bibr" rid="bib37">Kluger et al., 2013</xref>)</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td></tr><tr><td align="left" valign="bottom">Human great saphenous vein endothelial cells (HGSVECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib39">Latif et al., 2006</xref>; <xref ref-type="bibr" rid="bib50">Murakami et al., 2008</xref>)</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td></tr><tr><td align="left" valign="bottom">Human common carotid artery endothelial cells (HCCaECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>)</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td></tr><tr><td align="left" valign="bottom">Human aortic endothelial cells (HAoECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib83">Wu et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Sandig et al., 1999</xref>; <xref ref-type="bibr" rid="bib20">DeMaio et al., 2006</xref>)</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td></tr><tr><td align="left" valign="bottom">Human coronary artery endothelial cells (HCAECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib80">Wessells et al., 2009</xref>; <xref ref-type="bibr" rid="bib81">Wu et al., 2004</xref>; <xref ref-type="bibr" rid="bib59">Pinto et al., 2018</xref>)</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td></tr><tr><td align="left" valign="bottom">Human endocardial cells (HENDCs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib75">Vestweber et al., 2009</xref>; <xref ref-type="bibr" rid="bib6">Bao et al., 2017</xref>)</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td></tr><tr><td align="left" valign="bottom">Human renal artery endothelial cells (HRAECs) (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Chi et al., 2003</xref>; <xref ref-type="bibr" rid="bib46">Maciel et al., 2018</xref>)</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="char" char="." valign="bottom">+</td><td align="left" valign="bottom">−</td><td align="left" valign="bottom">−</td></tr></tbody></table></table-wrap><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Correlation between viral proteins and different types of vascular endothelial cells.</title><p>Correlation of adjusted p-value between vascular proteins identified in vascular endothelial cells and the viral proteins.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig6-v1.tif"/></fig><p>As our network propagation model is highly correlated with our experimental results, we applied it to other physiological systems that are known to be affected by SARS-CoV-2. We created a list of all proteins that are known to be affected by the SARS-CoV-2 proteins according to the literature (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>, white columns). The table was composed of both proteins identified experimentally via western blot, proteomics, and immunohistochemistry (marked in blue) and those identified clinically as being highly correlated with loss of specific functionality in specific tissues (marked in red). We then applied the network-based model to identify which proteins in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref> are most susceptible to the different SARS-CoV-2 proteins. As can be seen in <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplements 2</xref>–<xref ref-type="fig" rid="fig7s7">7</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A and B</xref>, specific SARS-CoV-2 proteins were identified as affecting specific proteins in specific tissues. As expected, most of the SARS-CoV-2 proteins affected more than one protein, the most salient being nsp11, nsp4, and nsp7 (<xref ref-type="fig" rid="fig7">Figure 7b</xref>), each of which was predicted to affect more than 40 different proteins. An additional parameter that should be considered is the protein’s ‘distance’ from the viral proteins. This value represents the number of hops in the PPI network from a given protein to the viral proteins, where a value of 1 represents a direct viral–host connection. We hypothesized that the closer the distance between the viral proteins and the given protein, the more significant the viral effect. <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref> (gray columns) and <xref ref-type="fig" rid="fig7">Figure 7c</xref> present the calculated distances. Most of the identified proteins in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref> were classified with a distance of 1 or 2 from the virus, suggesting more severe putative effects. A very clear example, are the T cells, macrophages, lung epithelial and cardiomyocytes which show that the most significant effect was by the viral proteins which present a close connection with the relative cell proteins reported. This suggest a potential effect on the related functional or metabolic pathway (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Protein identification using protein–protein interaction (PPI).</title><p>(a) PPI results for the severe acute respiratory syndrome (SARS)-CoV-2 proteins that have a significant effect on the proteins presented in SI <xref ref-type="table" rid="table1">Table 1</xref> for each system; (<bold>b</bold>) number of proteins affected by each SARS-CoV-2 protein, as calculated by PPI; (<bold>c</bold>) number of proteins with a specific distance factor from the viral proteins (also shown in SI <xref ref-type="table" rid="table1">Table 1</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Cardiomyocytes.</title><p>p-Value correlation of a target protein with a specific viral protein, calculated empirically using 100 random samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Enterocytes.</title><p>p-Value correlation of a target protein with a specific viral protein, calculated empirically using 100 random samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-figsupp2-v1.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title>Lymphocytes.</title><p>p-Value correlation of a target protein with a specific viral protein, calculated empirically using 100 random samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-figsupp3-v1.tif"/></fig><fig id="fig7s4" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 4.</label><caption><title>Lung.</title><p>p-Value correlation of a target protein with a specific viral protein, calculated empirically using 100 random samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-figsupp4-v1.tif"/></fig><fig id="fig7s5" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 5.</label><caption><title>Bronchial.</title><p>p-Value correlation of a target protein with a specific viral protein, calculated empirically using 100 random samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-figsupp5-v1.tif"/></fig><fig id="fig7s6" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 6.</label><caption><title>Proximal tubule cells.</title><p>p-Value correlation of a target protein with a specific viral protein, calculated empirically using 100 random samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-figsupp6-v1.tif"/></fig><fig id="fig7s7" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 7.</label><caption><title>Neuronal cells.</title><p>p-Value correlation of a target protein with a specific viral protein, calculated empirically using 100 random samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69314-fig7-figsupp7-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Due to the impact of SARS-CoV-2, many studies have looked at the physiological responses to the virus (<xref ref-type="bibr" rid="bib40">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="bib44">Libby and Lüscher, 2020</xref>; <xref ref-type="bibr" rid="bib70">Siddiqi et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Teuwen et al., 2020</xref>; <xref ref-type="bibr" rid="bib13">Chioh et al., 2020</xref>). In this work, we sought to identify how specific SARS-CoV-2 proteins affect the vasculature by assessing the effect of individual SARS-CoV-2 proteins on endothelial cells (HUVEC). This approach has significant advantages: it enables pinpointing and isolating how each of the SARS-CoV-2 proteins independently affects the endothelial response, and directly measuring endothelial functionality. The HUVEC model, derived from the umbilical cord, is physiologically representative of the human vascular endothelium, allowing the study of the physiological and pathological conditions as well as the effects of novel drugs on human endothelium (<xref ref-type="bibr" rid="bib8">Bouïs et al., 2001</xref>; <xref ref-type="bibr" rid="bib48">Medina-Leyte et al., 2020</xref>). Among technical advantages, cultured HUVECs are a simple in vitro vascular endothelial model, particularly suitable for studying endothelial properties and dynamics as well as the putative role of adhesion molecules, the synthesis of extracellular proteins and blood vessel maturation (<xref ref-type="bibr" rid="bib73">Vailhé et al., 2001</xref>).</p><p>The current study showed that almost 70 % (18 out of 26) of the SARS-CoV-2 proteins affect endothelial barrier integrity; however, the most significant proteins were nsp2, nsp5_c145a, and nsp7, which also induced upregulated expression of the coagulation factor VWF and cytokine release. These critical facts can shed light on the multiple pathologies observed in SARS-CoV-2 infection, including cytokine storm, increased coagulation and related diseases (e.g., heart attack and stroke) (<xref ref-type="bibr" rid="bib40">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="bib2">Aid et al., 2020</xref>), increased cardiovascular disease, and increased neurological symptoms. The results presented here showed an effect of in vitro cultured endothelial cells, which may lead to vasculature leakiness, consequently causing exotoxicity (i.e., the penetration of toxic reagents from the blood into the brain). While there are many parameters associated with functional changes, the use of advanced tools, including network-based analysis, enabled us to elucidate the specific proteins and the specific interactions that are predicted to cause these changes. The PPI network enabled us to predict that the changes observed in barrier function are possibly due to interactions between host proteins such as cadherin 2, α-catenin, β-catenin, δ-catenin, and ZO 1 and 2, and at least with the viral proteins nsp2, nsp5_c145a, and nsp7. Moreover, we validated our PPI model performing further immunostaining analysis demonstrating not only the ability of the viral proteins to strongly impair TJ expression, but also to confirm the data predicted by our model in which some TJ proteins can be more affected than others.</p><p>PPI analysis revealed a highly correlated effect of nsp7 and nsp13 on β-catenin in endothelial cells (<xref ref-type="fig" rid="fig4">Figure 4b</xref>; <xref ref-type="bibr" rid="bib30">Jung et al., 2020a</xref>; <xref ref-type="bibr" rid="bib41">Lengfeld et al., 2017</xref>). Interestingly, neither nsp2 nor nsp5_c145a affected a high number of proteins (<xref ref-type="fig" rid="fig7">Figure 7b</xref>), whereas nsp7 did, as identified by the network. Analyzing the repertoire of SARS-CoV-2 proteins, we see almost no effect of the structural proteins; rather, mostly nonstructural and open reading frame proteins affected HUVEC functionality, manifested as decreased barrier function and increased cytokine secretion (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>). While the nonstructural proteins are mainly responsible for replicating viral RNA, the open reading frame proteins are related to counteraction with the host immune system; some of these are localized to the mitochondria and have been shown to alter the mitochondrial antiviral signaling pathway (<xref ref-type="bibr" rid="bib49">Miller et al., 2021</xref>). We found that the proteins most affecting barrier function (decreased TEER and decreased CD31, β-catenin, cadherin-5, and ZO-1 expression) and cytokine response (IL-6 secretion and VWF expression) were nsp2, nsp5_c145a, and nsp7 (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="fig" rid="fig6">Figure 6</xref>); nsp7 forms a replication complex with nsp8 and nsp12 that is essential for viral replication and transcription (<xref ref-type="bibr" rid="bib15">Cowen et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Peng et al., 2020a</xref>). <xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref> suggested that in the core polymerase complex nsp7–nsp8–nsp12, nsp12 is the catalytic subunit, and nsp7 and nsp8 function as cofactors. They further suggested that the mechanism of activation mainly involves the cofactors rather than the catalytic subunit (<xref ref-type="bibr" rid="bib57">Peng et al., 2020b</xref>). This might explain why we saw mainly an effect of the cofactor proteins on endothelial cells and almost no effect of the catalytic subunit. Network interactions <xref ref-type="bibr" rid="bib21">Díaz, 2020</xref> have shown that nsp7 has the most interactions with the host, suggesting a potential target for the treatment of COVID-19. Moreover, no mutations were found in nsp7 compared to nsp2 or nsp5_c145a (<xref ref-type="bibr" rid="bib33">Kaushal et al., 2020</xref>), suggesting a conserved protein with a vital function in virus survival. The nsp13 protein has both helicase activity and 5’ triphosphatase activity, which play an important role in mRNA capping. We saw a significant effect of nsp13 on barrier function, but hardly any effect on cytokine secretion. <xref ref-type="bibr" rid="bib11">Chen et al., 2020</xref>, suggested functional complexation between nsp8 and nsp12, the RdRp (RNA-dependent RNA polymerase) replication complex, and nsp13. Given the fact that we observed a substantial effect of nsp7 – one of the proteins of the replication complex – and an effect of nsp13 on HUVEC barrier function, complexation of nsp13 with the replication complex might indicate an important role for this complex in the impaired functionality of the HUVECs, and therefore in the propagation of the disease, and the known vascular damage seen in COVID-19 patients. As suggested by our model, nsp13 seems to have a strong effect also on other types of vascular endothelial cells (<xref ref-type="fig" rid="fig6">Figure 6</xref>) as well as on all cell types (<xref ref-type="fig" rid="fig7">Figure 7a</xref>), positioning nsp13 as one of the main targets for disease treatment.</p><p>It is important to note that the comparison between the different endothelial cell types revealed exciting differences in the TJ protein expression, which correlate to the different properties of the different cell types (<xref ref-type="bibr" rid="bib52">Nakato et al., 2019</xref>). One of the major differences was that some endothelial cell lines do not have cadherin at all (e.g., HAoEC), or very limited amount of cadherin (e.g., HPAEC, HUAEC, HGSVEC). Our model suggests that some endothelial types (e.g., HUVEC, HUAEC, HGSVEC, HCAEC) are more susceptible to the SARS-Cov-2 virus. It, therefore, suggests that the treatment of one type of endothelial cell might be different from another type but offers the PPI model as a tool for initial prediction. Overall, the combination of identifying the differences in the TJ protein expression between the different endothelial cells and the use of the PPI model enabled us to pinpoint the differences in susceptibility to the disease and to identify which specific proteins have the most significant effect.</p><p>Many studies have looked at the SARS-CoV-2 interaction with nonpulmonary/nonvascular tissues (e.g., neurons, hepatocytes, immune components such as lymphocytes, macrophages, etc.) (<xref ref-type="bibr" rid="bib40">Lee et al., 2021</xref>), as pathological studies identified a viral effect on these tissues, despite their very limited amount, or lack of ACE2 receptors. To better understand how SARS-CoV-2 interacts with and affects other tissues, we consolidated all of the proteins currently known to be affected by the virus into <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>. It is interesting to note that the most dominant SARS-CoV-2 proteins are nsp4, nsp11, and nsp7. <xref ref-type="bibr" rid="bib16">Davies et al., 2020</xref>, identified the interaction of nsp2 with nsp4, both involved in endoplasmic reticulum (ER) calcium signaling and mitochondrial biogenesis. This suggests a new functional role in the host ER and mitochondrial organelle contact process and calcium homeostasis.</p><p>By now it is clear that vasculature plays a significant role in the physiological response to the virus. However, it is still unclear how the virus affects the vasculature, and if it can be found in the blood. This is a critical question, as it has significant consequences on the extent of the virus’s ability to affect the vasculature. Current studies demonstrate that the pulmonary vasculature is significantly affected and is one of the dominant triggers for the pathologies mentioned above. However, involvement with the rest of the vasculature is still unclear, as is whether the virus can be found in an active form in the blood circulation (<xref ref-type="bibr" rid="bib56">Peng et al., 2020a</xref>; <xref ref-type="bibr" rid="bib10">Chang et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Orologas-Stavrou et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Andersson et al., 2020</xref>; <xref ref-type="bibr" rid="bib23">Escribano et al., 2020</xref>; <xref ref-type="bibr" rid="bib78">Wang et al., 2020b</xref>). Some studies suggest that even if there are traces of SARS-CoV-2 in the blood, it is not in an active form and cannot cause disease or a systemic response (<xref ref-type="bibr" rid="bib5">Andersson et al., 2020</xref>). On the other hand, some studies suggest that SARS-CoV-2 can be found in the blood, and can induce the disease and cause both cellular and systemic dysfunction (<xref ref-type="bibr" rid="bib56">Peng et al., 2020a</xref>; <xref ref-type="bibr" rid="bib10">Chang et al., 2020</xref>; <xref ref-type="bibr" rid="bib23">Escribano et al., 2020</xref>). While this question is beyond the scope of this work, it is important to note that if future studies do identify the active form of SARS-CoV-2 in human blood, then the implications of our findings will apply to this systemic response as well (<xref ref-type="bibr" rid="bib1">Ahmed et al., 2020</xref>; <xref ref-type="bibr" rid="bib55">Park et al., 2020</xref>).</p><p>As already noted, the pathology is probably a combination of multiple conditions and pathways activated by the different proteins. However, our findings might open new avenues for future therapeutics. Moreover, most of the proteins that were identified as affected by SARS-CoV-2 had a distance factor of at most three to the human and viral proteins. This coincides with the current dogma, whereby proteins that have a shorter distance between them are more likely to be affected.</p><p>While beneficial, our approach has two major limitations: (a) our inability to identify the effect of multiple proteins and (b) our neglect of the effect of the coronavirus structure and binding on the cellular response. The former point can be overcome by expressing combinations of different SARS-CoV-2 proteins. However, since the SARS-CoV-2 expresses 29 proteins, there are about ~9 × 10<sup>30</sup> possible protein combinations. Therefore, we decided to focus on individual proteins and allow further studies to pursue any combinations of interest. Regarding the latter limitation, we did not include the coronavirus structure (including the ACE2 receptors) in this study, because many studies have already demonstrated the cellular response to this structure (<xref ref-type="bibr" rid="bib13">Chioh et al., 2020</xref>; <xref ref-type="bibr" rid="bib85">Yang et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Procko, 2020</xref>), and how tissues that do not have significant ACE2 expression (neurons, immune components such as B and T lymphocytes, and macrophages) are affected by the virus remains an open question.</p><sec id="s3-1"><title>Conclusions</title><p>Accumulating clinical evidence suggests that COVID-19 is a disease with vascular aspects. However, only a few studies have identified the specific role of each of the SARS-CoV-2 proteins in the cellular response leading to vascular dysfunctions. In this work, we characterized the endothelial response to each of 26 SARS-CoV-2 proteins and identified those that have the most significant effect on the barrier function. In addition, we used PPI network-based analysis to predict which of the endothelial proteins is most affected by the virus and to identify the specific role of each of the SARS-CoV-2 proteins in the observed changes in systemic protein expression. Overall, this work identified which of the SARS-CoV-2 proteins are most dominant in their effect on the physiological response to the virus. We believe that the data presented in this work will give us better insight into the mechanism by which the vasculature and the system respond to the virus, and will enable us to expedite drug development for the virus by targeting the identified dominant proteins.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Generation of lentiviral SARS-CoV-2 plasmids</title><p>Plasmids encoding the SARS-CoV-2 open reading frames proteins and eGFP control were a kind gift of Nevan Krogan (Addgene plasmid #141367–141395). Plasmids were acquired as bacterial LB–agar stabs and used per the provider’s instructions. Briefly, each stab was first seeded in LB agar (Bacto Agar; BD Biosciences, San Jose, CA) in 10 cm plates. Then, single colonies were inoculated into flasks containing LB (BD Difco LB Broth, Lennox) and 100 µg/ml penicillin (Biological Industries, Beit HaEmek, Israel). Transfection-grade plasmid DNA was isolated from each flask using the ZymoPURE II Plasmid Maxiprep Kit (Zymo Research, Irvine, CA) according to the manufacturer’s instructions.</p></sec><sec id="s4-2"><title>Lentivirus preparation</title><p>HEK293T cells (ATCC, Manassas, VA) were seeded in 10 cm cell culture plates at a density of 4 × 10<sup>6</sup> cells/plate. The cells were maintained in 293T medium composed of DMEM high glucose (4.5 g/l; Merck, Rahway, NJ) supplemented with 10 % fetal bovine serum (FBS; Biological Industries), 1× NEAA (Biological Industries), and 2 mM L-alanine–L-glutamine (Biological Industries, Israel). Lentiviral stocks, pseudo-typed with VSV-G, were produced in HEK293T cells as previously described (<xref ref-type="bibr" rid="bib38">Kutner et al., 2009</xref>). Briefly, each of the pLVX plasmids containing the SARS-CoV-2 genes or EGFP for control were cotransfected with third-generation lentivirus helper plasmids at equimolar ratio; 48 hr later, the lentivirus-containing medium was collected and supernatant was clarified by centrifugation (500 g, 5 min) and filtration (0.45 µm, Millex-HV, Merck Millipore, Burlington, MA). All virus stocks were aliquoted and stored at –80 °C until thawed for subsequent use.</p></sec><sec id="s4-3"><title>Endothelial cell culture</title><p>HUVECs (C-12200, PromoCell GmbH, Heidelberg, Germany, tested negative for mycoplasma contamination) were used to test each viral protein’s impact on vascular properties. After thawing, the HUVECs were expanded in low-serum endothelial cell growth medium (PromoCell) at 37°C with 5% CO<sub>2</sub> in a humidifying incubator, and used at passage p4–p6. Cells were grown to 80–90% confluence before being transferred to transparent polyethylene terephthalate Transwell supports (0.4 µm pore size, Greiner Bio-One, Austria) or a glass-bottom well plate (Cellvis, Mountain View, CA). Before seeding, the uncoated substrates were treated with Entactin-Collagen IV-Laminin (ECL) Cell Attachment Matrix (Merck) diluted in DMEM (10 µg/cm<sup>2</sup>) for 1 hr in the incubator. Then, the HUVECs were harvested using a DetachKit (PromoCell), were seeded inside the culture platforms at a density of 250,000 cells/cm<sup>2</sup>, and grown for 3 days. Then viral infection with the different plasmids was performed and its impact on cell behavior was tested 3 days later.</p></sec><sec id="s4-4"><title>TEER measurement</title><p>The barrier properties of the endothelial monolayer were evaluated by TEER measurements, 3 and 4 days after viral infection. TEER was measured with the Millicell ERS-2 Voltohmmeter (Merck Millipore). TEER values (Ω cm<sup>2</sup>) were calculated and compared to those obtained in a Transwell insert without cells, considered as a blank, in three different individual experiments, with two inserts used for each viral protein.</p></sec><sec id="s4-5"><title>Immunofluorescence</title><p>HUVEC plated on glass-bottom plates were rinsed in phosphate buffered saline (PBS) and fixed in 4 % paraformaldehyde (Sigma-Aldrich, Rehovot, Israel) for 20 min at RT, 5 days after viral infection. ICC was carried out after permeabilization with 0.1 % Triton X-100 (Sigma-Aldrich, Rehovot, Israel) in PBS for 10 min at RT and blocking for 30 min with 5 % FBS in PBS. The following primary antibodies were applied overnight in PBS at 4°C: rabbit anti-VWF (Abcam, Cambridge, UK), rabbit anti-CD31 (Abcam) against platelet endothelial cell adhesion molecule 1 (PECAM1), rabbit anti-β-catenin (Cell Signaling Technology, Danvers, MA), rabbit anti-cadherin-5 (Cell Signaling Technology, Danvers, MA), rabbit anti ZO-1 (Cell Signaling Technology, Danvers, MA), rabbit anti-occludin (Cell Signaling Technology, Danvers, MA). Cells were then washed three times in PBS and stained with the secondary antibody, anti-rabbit Alexa Fluor 488 (Invitrogen, Carlsbad, CA), for 1 hr at RT. After four washes with PBS, cells were incubated with Hoechst in PBS for 10 min at RT to stain the nuclei. After two washes with PBS, imaging was carried out using an inverted confocal microscope (Olympus FV3000-IX83) with suitable filter cubes and equipped with 20× (0.8 NA), 40× (0.95 NA), and 60× (1.42 NA) objectives. Image reconstruction and analysis were done using open-source ImageJ software (<xref ref-type="bibr" rid="bib69">Schindelin et al., 2012</xref>).</p></sec><sec id="s4-6"><title>Network analysis</title><p>We scored the effect of each viral protein on selected human proteins using network propagation (<xref ref-type="bibr" rid="bib15">Cowen et al., 2017</xref>). Specifically, a viral protein was represented by the set of its human interactors (<xref ref-type="bibr" rid="bib27">Hu et al., 2021</xref>); each of these received a prior score, equal to 1 /n, where n is the size of the interactor set; these scores were propagated in a network of PPI (<xref ref-type="bibr" rid="bib4">Almozlino et al., 2017</xref>). To assess the statistical significance of the obtained scores, we compared them to those computed on 1000 randomized networks that preserve node degrees. The PPI score was then compared versus the other random networks (this is empirical p-value). p-Values were adjusted for multiple testing using Benjamini–Hochberg FDR approach. For display purposes, the plotted p-value is the negative log of the p-value, which means numbers are non-negative and the higher is the more significant.</p></sec><sec id="s4-7"><title>Quantitative ELISA for IL-6</title><p>ELISA was performed on conditioned medium of infected HUVEC 3 days postinfection, according to the manufacturer’s recommendations (PeproTech Rehovot, Israel).</p></sec><sec id="s4-8"><title>Statistical analysis</title><p>The results are presented as mean ± SD, unless otherwise indicated. Statistically significant differences among multiple groups were evaluated by F-statistic with two-way ANOVA, followed by the Holm–Sidak test for multiple comparisons (GraphPad Prism 8.4.3). The difference between the two data sets was assessed and p &lt; 0.05 was considered statistically significant.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Methodology, Project administration, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Investigation, Methodology, Visualization</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Investigation, Methodology, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Software</p></fn><fn fn-type="con" id="con5"><p>Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con10"><p>Methodology, Resources</p></fn><fn fn-type="con" id="con11"><p>Methodology, Resources</p></fn><fn fn-type="con" id="con12"><p>Methodology, Resources</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Software</p></fn><fn fn-type="con" id="con14"><p>Funding acquisition, Investigation, Supervision, Writing – original draft</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – original draft</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Protein change by SARS-Cov-2.</title><p>(<bold>A</bold>) Documented change by severe acute respiratory syndrome (SARS)-Cov-2. (<bold>B</bold>) Significant target for each viral protein.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-69314-supp1-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-69314-transrepform1-v1.docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>The source data file contains all the data that was used for <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>, and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69314-supp2-v1.xlsx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. The custom scripts available in GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/raminass/covid_networks">https://github.com/raminass/covid_networks</ext-link>, (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:b239ae7e0e72b722beb6d694436068541ea28dbb">https://archive.softwareheritage.org/swh:1:rev:b239ae7e0e72b722beb6d694436068541ea28dbb</ext-link>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>BMM was supported by the Azrieli Foundation, Israel Science Foundation (ISF grant: 2248/19), ERC SweetBrain 851765, TEVA, The Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease at Tel Aviv University, Zimin, Israel Ministry of Science and Technology (Grant No. 3–17351), and TCCP. UA was supported by the Israel Science Foundation (ISF grant 953/16), TEVA, The Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease at Tel Aviv University, the German Research Foundation (DFG) (NA: 207/10–1) and the Taube/Koret Global Collaboration in Neurodegenerative Diseases. RS was supported by the Israel Science Foundation (ISF grant 2417/20), within the Israel Precision Medicine Partership program. The work of YN, AE, and KI was supported by European Research Council Consolidator Grant OCLD (project no. 681870).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>H</given-names></name><name><surname>Sayed</surname><given-names>A</given-names></name><name><surname>Munir</surname><given-names>M</given-names></name><name><surname>Elberry</surname><given-names>MH</given-names></name><name><surname>Sayed</surname><given-names>IM</given-names></name><name><surname>Kamal</surname><given-names>MA</given-names></name><name><surname>Negida</surname><given-names>A</given-names></name><name><surname>Ebada</surname><given-names>MA</given-names></name><name><surname>Bahbah</surname><given-names>EI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management</article-title><source>Current Pharmaceutical Design</source><volume>1</volume><elocation-id>509</elocation-id><pub-id pub-id-type="doi">10.2174/1381612826666201222162509</pub-id><pub-id pub-id-type="pmid">33355050</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aid</surname><given-names>M</given-names></name><name><surname>Busman-Sahay</surname><given-names>K</given-names></name><name><surname>Vidal</surname><given-names>SJ</given-names></name><name><surname>Maliga</surname><given-names>Z</given-names></name><name><surname>Bondoc</surname><given-names>S</given-names></name><name><surname>Starke</surname><given-names>C</given-names></name><name><surname>Terry</surname><given-names>M</given-names></name><name><surname>Jacobson</surname><given-names>CA</given-names></name><name><surname>Wrijil</surname><given-names>L</given-names></name><name><surname>Ducat</surname><given-names>S</given-names></name><name><surname>Brook</surname><given-names>OR</given-names></name><name><surname>Miller</surname><given-names>AD</given-names></name><name><surname>Porto</surname><given-names>M</given-names></name><name><surname>Pellegrini</surname><given-names>KL</given-names></name><name><surname>Pino</surname><given-names>M</given-names></name><name><surname>Hoang</surname><given-names>TN</given-names></name><name><surname>Chandrashekar</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Stephenson</surname><given-names>K</given-names></name><name><surname>Bosinger</surname><given-names>SE</given-names></name><name><surname>Andersen</surname><given-names>H</given-names></name><name><surname>Lewis</surname><given-names>MG</given-names></name><name><surname>Hecht</surname><given-names>JL</given-names></name><name><surname>Sorger</surname><given-names>PK</given-names></name><name><surname>Martinot</surname><given-names>AJ</given-names></name><name><surname>Estes</surname><given-names>JD</given-names></name><name><surname>Barouch</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques</article-title><source>Cell</source><volume>183</volume><fpage>1354</fpage><lpage>1366</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.10.005</pub-id><pub-id pub-id-type="pmid">33065030</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbari</surname><given-names>A</given-names></name><name><surname>Rezaie</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia</article-title><source>Stem Cell Research &amp; Therapy</source><volume>11</volume><elocation-id>356</elocation-id><pub-id pub-id-type="doi">10.1186/s13287-020-01866-6</pub-id><pub-id pub-id-type="pmid">32795359</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almozlino</surname><given-names>Y</given-names></name><name><surname>Atias</surname><given-names>N</given-names></name><name><surname>Silverbush</surname><given-names>D</given-names></name><name><surname>Sharan</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ANAT 2.0: reconstructing functional protein subnetworks</article-title><source>BMC Bioinformatics</source><volume>18</volume><elocation-id>495</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-017-1932-1</pub-id><pub-id pub-id-type="pmid">29145805</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>MI</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>CV</given-names></name><name><surname>Auckland</surname><given-names>K</given-names></name><name><surname>Baillie</surname><given-names>JK</given-names></name><name><surname>Barnes</surname><given-names>E</given-names></name><name><surname>Beneke</surname><given-names>T</given-names></name><name><surname>Bibi</surname><given-names>S</given-names></name><name><surname>Brooks</surname><given-names>T</given-names></name><name><surname>Carroll</surname><given-names>M</given-names></name><name><surname>Crook</surname><given-names>D</given-names></name><name><surname>Dingle</surname><given-names>K</given-names></name><name><surname>Dold</surname><given-names>C</given-names></name><name><surname>Downs</surname><given-names>LO</given-names></name><name><surname>Dunn</surname><given-names>L</given-names></name><name><surname>Eyre</surname><given-names>DW</given-names></name><name><surname>Gilbert Jaramillo</surname><given-names>J</given-names></name><name><surname>Harvala</surname><given-names>H</given-names></name><name><surname>Hoosdally</surname><given-names>S</given-names></name><name><surname>Ijaz</surname><given-names>S</given-names></name><name><surname>James</surname><given-names>T</given-names></name><name><surname>James</surname><given-names>W</given-names></name><name><surname>Jeffery</surname><given-names>K</given-names></name><name><surname>Justice</surname><given-names>A</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name><name><surname>Knight</surname><given-names>JC</given-names></name><name><surname>Knight</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Lumley</surname><given-names>SF</given-names></name><name><surname>Matthews</surname><given-names>PC</given-names></name><name><surname>McNaughton</surname><given-names>AL</given-names></name><name><surname>Mentzer</surname><given-names>AJ</given-names></name><name><surname>Mongkolsapaya</surname><given-names>J</given-names></name><name><surname>Oakley</surname><given-names>S</given-names></name><name><surname>Oliveira</surname><given-names>MS</given-names></name><name><surname>Peto</surname><given-names>T</given-names></name><name><surname>Ploeg</surname><given-names>RJ</given-names></name><name><surname>Ratcliff</surname><given-names>J</given-names></name><name><surname>Robbins</surname><given-names>MJ</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Rudkin</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>RA</given-names></name><name><surname>Screaton</surname><given-names>G</given-names></name><name><surname>Semple</surname><given-names>MG</given-names></name><name><surname>Skelly</surname><given-names>D</given-names></name><name><surname>Simmonds</surname><given-names>P</given-names></name><name><surname>Stoesser</surname><given-names>N</given-names></name><name><surname>Turtle</surname><given-names>L</given-names></name><name><surname>Wareing</surname><given-names>S</given-names></name><name><surname>Zambon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus</article-title><source>Wellcome Open Research</source><volume>5</volume><elocation-id>181</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.16002.2</pub-id><pub-id pub-id-type="pmid">33283055</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>X</given-names></name><name><surname>Bhute</surname><given-names>VJ</given-names></name><name><surname>Han</surname><given-names>T</given-names></name><name><surname>Qian</surname><given-names>T</given-names></name><name><surname>Lian</surname><given-names>X</given-names></name><name><surname>Palecek</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human pluripotent stem cell-derived epicardial progenitors can differentiate to endocardial-like endothelial cells</article-title><source>Bioengineering &amp; Translational Medicine</source><volume>2</volume><fpage>191</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1002/btm2.10062</pub-id><pub-id pub-id-type="pmid">29170757</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>LC</given-names></name><name><surname>Gonçalves</surname><given-names>TL</given-names></name><name><surname>de Araujo</surname><given-names>LP</given-names></name><name><surname>de Rosario</surname><given-names>L</given-names></name><name><surname>Ferrer</surname><given-names>VP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Endothelial cells and SARS-CoV-2: An intimate relationship</article-title><source>Vascular Pharmacology</source><volume>137</volume><elocation-id>106829</elocation-id><pub-id pub-id-type="doi">10.1016/j.vph.2021.106829</pub-id><pub-id pub-id-type="pmid">33422689</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouïs</surname><given-names>D</given-names></name><name><surname>Hospers</surname><given-names>GA</given-names></name><name><surname>Meijer</surname><given-names>C</given-names></name><name><surname>Molema</surname><given-names>G</given-names></name><name><surname>Mulder</surname><given-names>NH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research</article-title><source>Angiogenesis</source><volume>4</volume><fpage>91</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1023/a:1012259529167</pub-id><pub-id pub-id-type="pmid">11806248</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzhdygan</surname><given-names>TP</given-names></name><name><surname>DeOre</surname><given-names>BJ</given-names></name><name><surname>Baldwin-Leclair</surname><given-names>A</given-names></name><name><surname>Bullock</surname><given-names>TA</given-names></name><name><surname>McGary</surname><given-names>HM</given-names></name><name><surname>Khan</surname><given-names>JA</given-names></name><name><surname>Razmpour</surname><given-names>R</given-names></name><name><surname>Hale</surname><given-names>JF</given-names></name><name><surname>Galie</surname><given-names>PA</given-names></name><name><surname>Potula</surname><given-names>R</given-names></name><name><surname>Andrews</surname><given-names>AM</given-names></name><name><surname>Ramirez</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier</article-title><source>Neurobiology of Disease</source><volume>146</volume><elocation-id>105131</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2020.105131</pub-id><pub-id pub-id-type="pmid">33053430</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coronavirus Disease 2019: Coronaviruses and Blood Safety</article-title><source>Transfusion Medicine Reviews</source><volume>34</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.tmrv.2020.02.003</pub-id><pub-id pub-id-type="pmid">32107119</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Malone</surname><given-names>B</given-names></name><name><surname>Llewellyn</surname><given-names>E</given-names></name><name><surname>Grasso</surname><given-names>M</given-names></name><name><surname>Shelton</surname><given-names>PMM</given-names></name><name><surname>Olinares</surname><given-names>PDB</given-names></name><name><surname>Maruthi</surname><given-names>K</given-names></name><name><surname>Eng</surname><given-names>ET</given-names></name><name><surname>Vatandaslar</surname><given-names>H</given-names></name><name><surname>Chait</surname><given-names>BT</given-names></name><name><surname>Kapoor</surname><given-names>TM</given-names></name><name><surname>Darst</surname><given-names>SA</given-names></name><name><surname>Campbell</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex</article-title><source>Cell</source><volume>182</volume><fpage>1560</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.07.033</pub-id><pub-id pub-id-type="pmid">32783916</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>JT</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Haraldsen</surname><given-names>G</given-names></name><name><surname>Jahnsen</surname><given-names>FL</given-names></name><name><surname>Troyanskaya</surname><given-names>OG</given-names></name><name><surname>Chang</surname><given-names>DS</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Rockson</surname><given-names>SG</given-names></name><name><surname>van de Rijn</surname><given-names>M</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Endothelial cell diversity revealed by global expression profiling</article-title><source>PNAS</source><volume>100</volume><fpage>10623</fpage><lpage>10628</lpage><pub-id pub-id-type="doi">10.1073/pnas.1434429100</pub-id><pub-id pub-id-type="pmid">12963823</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Chioh</surname><given-names>FWJ</given-names></name><name><surname>Fong</surname><given-names>SW</given-names></name><name><surname>Young</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Convalescent COVID-19 Patients Are Susceptible to Endothelial Dysfunction Due to Persistent Immune Activation</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.11.16.20232835v1</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornillez-Ty</surname><given-names>CT</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Yates</surname><given-names>JR</given-names></name><name><surname>Kuhn</surname><given-names>P</given-names></name><name><surname>Buchmeier</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling</article-title><source>Journal of Virology</source><volume>83</volume><fpage>10314</fpage><lpage>10318</lpage><pub-id pub-id-type="doi">10.1128/JVI.00842-09</pub-id><pub-id pub-id-type="pmid">19640993</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowen</surname><given-names>L</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name><name><surname>Raphael</surname><given-names>BJ</given-names></name><name><surname>Sharan</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Network propagation: a universal amplifier of genetic associations</article-title><source>Nature Reviews. Genetics</source><volume>18</volume><fpage>551</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1038/nrg.2017.38</pub-id><pub-id pub-id-type="pmid">28607512</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>JP</given-names></name><name><surname>Almasy</surname><given-names>KM</given-names></name><name><surname>McDonald</surname><given-names>EF</given-names></name><name><surname>Plate</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies</article-title><source>ACS Infectious Diseases</source><volume>6</volume><fpage>3174</fpage><lpage>3189</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00500</pub-id><pub-id pub-id-type="pmid">33263384</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>MA</given-names></name><name><surname>Ireton</surname><given-names>RC</given-names></name><name><surname>Reynolds</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A core function for p120-catenin in cadherin turnover</article-title><source>The Journal of Cell Biology</source><volume>163</volume><fpage>525</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1083/jcb.200307111</pub-id><pub-id pub-id-type="pmid">14610055</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>WL</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Cummins</surname><given-names>TD</given-names></name><name><surname>Schultz</surname><given-names>DJ</given-names></name><name><surname>Powell</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Proteomic and functional characterisation of platelet microparticle size classes</article-title><source>Thrombosis and Haemostasis</source><volume>102</volume><fpage>711</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1160/TH09-04-243</pub-id><pub-id pub-id-type="pmid">19806257</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBusk</surname><given-names>LM</given-names></name><name><surname>Boelte</surname><given-names>K</given-names></name><name><surname>Min</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Heterozygous deficiency of delta-catenin impairs pathological angiogenesis</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1084/jem.20091097</pub-id><pub-id pub-id-type="pmid">20048286</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeMaio</surname><given-names>L</given-names></name><name><surname>Rouhanizadeh</surname><given-names>M</given-names></name><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Sevanian</surname><given-names>A</given-names></name><name><surname>Hwang</surname><given-names>J</given-names></name><name><surname>Hsiai</surname><given-names>TK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>290</volume><fpage>H674</fpage><lpage>H683</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00554.2005</pub-id><pub-id pub-id-type="pmid">16172163</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Díaz</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 Molecular Network Structure</article-title><source>Frontiers in Physiology</source><volume>11</volume><elocation-id>870</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2020.00870</pub-id><pub-id pub-id-type="pmid">32754056</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiStefano</surname><given-names>PV</given-names></name><name><surname>Kuebel</surname><given-names>JM</given-names></name><name><surname>Sarelius</surname><given-names>IH</given-names></name><name><surname>Glading</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling</article-title><source>The Journal of Biological Chemistry</source><volume>289</volume><fpage>33054</fpage><lpage>33065</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.582304</pub-id><pub-id pub-id-type="pmid">25320085</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escribano</surname><given-names>P</given-names></name><name><surname>Álvarez-Uría</surname><given-names>A</given-names></name><name><surname>Alonso</surname><given-names>R</given-names></name><name><surname>Catalán</surname><given-names>P</given-names></name><name><surname>Alcalá</surname><given-names>L</given-names></name><name><surname>Muñoz</surname><given-names>P</given-names></name><name><surname>Guinea</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>19893</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-76914-5</pub-id><pub-id pub-id-type="pmid">33199713</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreri</surname><given-names>DM</given-names></name><name><surname>Minnear</surname><given-names>FL</given-names></name><name><surname>Yin</surname><given-names>T</given-names></name><name><surname>Kowalczyk</surname><given-names>AP</given-names></name><name><surname>Vincent</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>N-cadherin levels in endothelial cells are regulated by monolayer maturity and p120 availability</article-title><source>Cell Communication &amp; Adhesion</source><volume>15</volume><fpage>333</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1080/15419060802440377</pub-id><pub-id pub-id-type="pmid">18979298</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>DE</given-names></name><name><surname>Jang</surname><given-names>GM</given-names></name><name><surname>Bouhaddou</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Obernier</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>KM</given-names></name><name><surname>O’Meara</surname><given-names>MJ</given-names></name><name><surname>Rezelj</surname><given-names>VV</given-names></name><name><surname>Guo</surname><given-names>JZ</given-names></name><name><surname>Swaney</surname><given-names>DL</given-names></name><name><surname>Tummino</surname><given-names>TA</given-names></name><name><surname>Hüttenhain</surname><given-names>R</given-names></name><name><surname>Kaake</surname><given-names>RM</given-names></name><name><surname>Richards</surname><given-names>AL</given-names></name><name><surname>Tutuncuoglu</surname><given-names>B</given-names></name><name><surname>Foussard</surname><given-names>H</given-names></name><name><surname>Batra</surname><given-names>J</given-names></name><name><surname>Haas</surname><given-names>K</given-names></name><name><surname>Modak</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Haas</surname><given-names>P</given-names></name><name><surname>Polacco</surname><given-names>BJ</given-names></name><name><surname>Braberg</surname><given-names>H</given-names></name><name><surname>Fabius</surname><given-names>JM</given-names></name><name><surname>Eckhardt</surname><given-names>M</given-names></name><name><surname>Soucheray</surname><given-names>M</given-names></name><name><surname>Bennett</surname><given-names>MJ</given-names></name><name><surname>Cakir</surname><given-names>M</given-names></name><name><surname>McGregor</surname><given-names>MJ</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Meyer</surname><given-names>B</given-names></name><name><surname>Roesch</surname><given-names>F</given-names></name><name><surname>Vallet</surname><given-names>T</given-names></name><name><surname>Mac Kain</surname><given-names>A</given-names></name><name><surname>Miorin</surname><given-names>L</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name><name><surname>Naing</surname><given-names>ZZC</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Shen</surname><given-names>W</given-names></name><name><surname>Kirby</surname><given-names>IT</given-names></name><name><surname>Melnyk</surname><given-names>JE</given-names></name><name><surname>Chorba</surname><given-names>JS</given-names></name><name><surname>Lou</surname><given-names>K</given-names></name><name><surname>Dai</surname><given-names>SA</given-names></name><name><surname>Barrio-Hernandez</surname><given-names>I</given-names></name><name><surname>Memon</surname><given-names>D</given-names></name><name><surname>Hernandez-Armenta</surname><given-names>C</given-names></name><name><surname>Lyu</surname><given-names>J</given-names></name><name><surname>Mathy</surname><given-names>CJP</given-names></name><name><surname>Perica</surname><given-names>T</given-names></name><name><surname>Pilla</surname><given-names>KB</given-names></name><name><surname>Ganesan</surname><given-names>SJ</given-names></name><name><surname>Saltzberg</surname><given-names>DJ</given-names></name><name><surname>Rakesh</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Rosenthal</surname><given-names>SB</given-names></name><name><surname>Calviello</surname><given-names>L</given-names></name><name><surname>Venkataramanan</surname><given-names>S</given-names></name><name><surname>Liboy-Lugo</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>XP</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wankowicz</surname><given-names>SA</given-names></name><name><surname>Bohn</surname><given-names>M</given-names></name><name><surname>Safari</surname><given-names>M</given-names></name><name><surname>Ugur</surname><given-names>FS</given-names></name><name><surname>Koh</surname><given-names>C</given-names></name><name><surname>Savar</surname><given-names>NS</given-names></name><name><surname>Tran</surname><given-names>QD</given-names></name><name><surname>Shengjuler</surname><given-names>D</given-names></name><name><surname>Fletcher</surname><given-names>SJ</given-names></name><name><surname>O’Neal</surname><given-names>MC</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>JCJ</given-names></name><name><surname>Broadhurst</surname><given-names>DJ</given-names></name><name><surname>Klippsten</surname><given-names>S</given-names></name><name><surname>Sharp</surname><given-names>PP</given-names></name><name><surname>Wenzell</surname><given-names>NA</given-names></name><name><surname>Kuzuoglu-Ozturk</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Trenker</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>JM</given-names></name><name><surname>Cavero</surname><given-names>DA</given-names></name><name><surname>Hiatt</surname><given-names>J</given-names></name><name><surname>Roth</surname><given-names>TL</given-names></name><name><surname>Rathore</surname><given-names>U</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Noack</surname><given-names>J</given-names></name><name><surname>Hubert</surname><given-names>M</given-names></name><name><surname>Stroud</surname><given-names>RM</given-names></name><name><surname>Frankel</surname><given-names>AD</given-names></name><name><surname>Rosenberg</surname><given-names>OS</given-names></name><name><surname>Verba</surname><given-names>KA</given-names></name><name><surname>Agard</surname><given-names>DA</given-names></name><name><surname>Ott</surname><given-names>M</given-names></name><name><surname>Emerman</surname><given-names>M</given-names></name><name><surname>Jura</surname><given-names>N</given-names></name><name><surname>von Zastrow</surname><given-names>M</given-names></name><name><surname>Verdin</surname><given-names>E</given-names></name><name><surname>Ashworth</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>O</given-names></name><name><surname>d’Enfert</surname><given-names>C</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Jacobson</surname><given-names>M</given-names></name><name><surname>Malik</surname><given-names>HS</given-names></name><name><surname>Fujimori</surname><given-names>DG</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name><name><surname>Craik</surname><given-names>CS</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name><name><surname>Fraser</surname><given-names>JS</given-names></name><name><surname>Gross</surname><given-names>JD</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name><name><surname>Roth</surname><given-names>BL</given-names></name><name><surname>Ruggero</surname><given-names>D</given-names></name><name><surname>Taunton</surname><given-names>J</given-names></name><name><surname>Kortemme</surname><given-names>T</given-names></name><name><surname>Beltrao</surname><given-names>P</given-names></name><name><surname>Vignuzzi</surname><given-names>M</given-names></name><name><surname>García-Sastre</surname><given-names>A</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name><name><surname>Krogan</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title><source>Nature</source><volume>583</volume><fpage>459</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2286-9</pub-id><pub-id pub-id-type="pmid">32353859</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillen</surname><given-names>HS</given-names></name><name><surname>Kokic</surname><given-names>G</given-names></name><name><surname>Farnung</surname><given-names>L</given-names></name><name><surname>Dienemann</surname><given-names>C</given-names></name><name><surname>Tegunov</surname><given-names>D</given-names></name><name><surname>Cramer</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structure of replicating SARS-CoV-2 polymerase</article-title><source>Nature</source><volume>584</volume><fpage>154</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2368-8</pub-id><pub-id pub-id-type="pmid">32438371</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>ZL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Characteristics of SARS-CoV-2 and COVID-19</article-title><source>Nature Reviews. Microbiology</source><volume>19</volume><fpage>141</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1038/s41579-020-00459-7</pub-id><pub-id pub-id-type="pmid">33024307</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikuno</surname><given-names>T</given-names></name><name><surname>Masumoto</surname><given-names>H</given-names></name><name><surname>Yamamizu</surname><given-names>K</given-names></name><name><surname>Yoshioka</surname><given-names>M</given-names></name><name><surname>Minakata</surname><given-names>K</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>R</given-names></name><name><surname>Yamashita</surname><given-names>JK</given-names></name><name><surname>Rajasingh</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0173271</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0173271</pub-id><pub-id pub-id-type="pmid">28288160</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>KA</given-names></name><name><surname>Thiel</surname><given-names>V</given-names></name><name><surname>Dobbe</surname><given-names>JC</given-names></name><name><surname>van der Meer</surname><given-names>Y</given-names></name><name><surname>Snijder</surname><given-names>EJ</given-names></name><name><surname>Ziebuhr</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase</article-title><source>Journal of Virology</source><volume>78</volume><fpage>5619</fpage><lpage>5632</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.11.5619-5632.2004</pub-id><pub-id pub-id-type="pmid">15140959</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>GS</given-names></name><name><surname>Moon</surname><given-names>JH</given-names></name><name><surname>Ku</surname><given-names>K</given-names></name><name><surname>Beak</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>CS</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>EC</given-names></name><name><surname>Park</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Byeon</surname><given-names>CW</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Maeng</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>SI</given-names></name><name><surname>Kim</surname><given-names>BT</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>HG</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Comparative Analysis of Primer-Probe Sets for RT-qPCR of COVID-19 Causative Virus (SARS-CoV-2</article-title><source>ACS Infectious Diseases</source><volume>6</volume><fpage>2513</fpage><lpage>2523</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00464</pub-id><pub-id pub-id-type="pmid">32786273</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>F</given-names></name><name><surname>Krüger-Genge</surname><given-names>A</given-names></name><name><surname>Franke</surname><given-names>RP</given-names></name><name><surname>Hufert</surname><given-names>F</given-names></name><name><surname>Küpper</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>COVID-19 and the endothelium</article-title><source>Clinical Hemorheology and Microcirculation</source><volume>75</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3233/CH-209007</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname><given-names>N</given-names></name><name><surname>Satta</surname><given-names>S</given-names></name><name><surname>Komuro</surname><given-names>Y</given-names></name><name><surname>Muthukrishnan</surname><given-names>SD</given-names></name><name><surname>Kakarla</surname><given-names>V</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Elahi</surname><given-names>F</given-names></name><name><surname>Kornblum</surname><given-names>HI</given-names></name><name><surname>Liebeskind</surname><given-names>DS</given-names></name><name><surname>Hsiai</surname><given-names>T</given-names></name><name><surname>Hinman</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection</article-title><source>Stroke</source><volume>52</volume><fpage>260</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.120.032764</pub-id><pub-id pub-id-type="pmid">33161843</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushal</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>Y</given-names></name><name><surname>Goyal</surname><given-names>M</given-names></name><name><surname>Khaiboullina</surname><given-names>SF</given-names></name><name><surname>Baranwal</surname><given-names>M</given-names></name><name><surname>Verma</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA</article-title><source>Pathogens</source><volume>9</volume><elocation-id>E565</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens9070565</pub-id><pub-id pub-id-type="pmid">32668692</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawecki</surname><given-names>C</given-names></name><name><surname>Lenting</surname><given-names>PJ</given-names></name><name><surname>Denis</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>von Willebrand factor and inflammation</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>15</volume><fpage>1285</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1111/jth.13696</pub-id><pub-id pub-id-type="pmid">28671350</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kevil</surname><given-names>CG</given-names></name><name><surname>Okayama</surname><given-names>N</given-names></name><name><surname>Trocha</surname><given-names>SD</given-names></name><name><surname>Kalogeris</surname><given-names>TJ</given-names></name><name><surname>Coe</surname><given-names>LL</given-names></name><name><surname>Specian</surname><given-names>RD</given-names></name><name><surname>Davis</surname><given-names>CP</given-names></name><name><surname>Alexander</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Expression of zonula occludens and adherens junctional proteins in human venous and arterial endothelial cells: role of occludin in endothelial solute barriers</article-title><source>Microcirculation</source><volume>5</volume><fpage>197</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">9789260</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Yang</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>VN</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Architecture of SARS-CoV-2 Transcriptome</article-title><source>Cell</source><volume>181</volume><fpage>914</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.011</pub-id><pub-id pub-id-type="pmid">32330414</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kluger</surname><given-names>MS</given-names></name><name><surname>Clark</surname><given-names>PR</given-names></name><name><surname>Tellides</surname><given-names>G</given-names></name><name><surname>Gerke</surname><given-names>V</given-names></name><name><surname>Pober</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>33</volume><fpage>489</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.112.300893</pub-id><pub-id pub-id-type="pmid">23288152</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutner</surname><given-names>RH</given-names></name><name><surname>Zhang</surname><given-names>XY</given-names></name><name><surname>Reiser</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors</article-title><source>Nature Protocols</source><volume>4</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.22</pub-id><pub-id pub-id-type="pmid">19300443</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latif</surname><given-names>N</given-names></name><name><surname>Sarathchandra</surname><given-names>P</given-names></name><name><surname>Taylor</surname><given-names>PM</given-names></name><name><surname>Antoniw</surname><given-names>J</given-names></name><name><surname>Brand</surname><given-names>N</given-names></name><name><surname>Yacoub</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Characterization of molecules mediating cell-cell communication in human cardiac valve interstitial cells</article-title><source>Cell Biochemistry and Biophysics</source><volume>45</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1385/CBB:45:3:255</pub-id><pub-id pub-id-type="pmid">16845172</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Perl</surname><given-names>DP</given-names></name><name><surname>Nair</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Maric</surname><given-names>D</given-names></name><name><surname>Murray</surname><given-names>H</given-names></name><name><surname>Dodd</surname><given-names>SJ</given-names></name><name><surname>Koretsky</surname><given-names>AP</given-names></name><name><surname>Watts</surname><given-names>JA</given-names></name><name><surname>Cheung</surname><given-names>V</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Horkayne-Szakaly</surname><given-names>I</given-names></name><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Stram</surname><given-names>MN</given-names></name><name><surname>Moncur</surname><given-names>J</given-names></name><name><surname>Hefti</surname><given-names>M</given-names></name><name><surname>Folkerth</surname><given-names>RD</given-names></name><name><surname>Nath</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Microvascular Injury in the Brains of Patients with Covid-19</article-title><source>The New England Journal of Medicine</source><volume>384</volume><fpage>481</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2033369</pub-id><pub-id pub-id-type="pmid">33378608</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lengfeld</surname><given-names>JE</given-names></name><name><surname>Lutz</surname><given-names>SE</given-names></name><name><surname>Smith</surname><given-names>JR</given-names></name><name><surname>Diaconu</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>C</given-names></name><name><surname>Kofman</surname><given-names>SB</given-names></name><name><surname>Choi</surname><given-names>C</given-names></name><name><surname>Walsh</surname><given-names>CM</given-names></name><name><surname>Raine</surname><given-names>CS</given-names></name><name><surname>Agalliu</surname><given-names>I</given-names></name><name><surname>Agalliu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis</article-title><source>PNAS</source><volume>114</volume><fpage>E1168</fpage><lpage>E1177</lpage><pub-id pub-id-type="doi">10.1073/pnas.1609905114</pub-id><pub-id pub-id-type="pmid">28137846</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Mou</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>G</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Distinct infection process of SARS-CoV-2 in human bronchial epithelial cell lines</article-title><source>Journal of Medical Virology</source><volume>92</volume><fpage>2830</fpage><lpage>2838</lpage><pub-id pub-id-type="doi">10.1002/jmv.26200</pub-id><pub-id pub-id-type="pmid">32558946</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19</article-title><source>Nature Medicine</source><volume>26</volume><fpage>842</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0901-9</pub-id><pub-id pub-id-type="pmid">32398875</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Lüscher</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 is, in the end, an endothelial disease</article-title><source>European Heart Journal</source><volume>41</volume><fpage>3038</fpage><lpage>3044</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehaa623</pub-id><pub-id pub-id-type="pmid">32882706</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Mai</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Guan</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rhamnocitrin extracted from Nervilia fordii inhibited vascular endothelial activation via miR-185/STIM-1/SOCE/NFATc3</article-title><source>Phytomedicine : International Journal of Phytotherapy and Phytopharmacology</source><volume>79</volume><elocation-id>153350</elocation-id><pub-id pub-id-type="doi">10.1016/j.phymed.2020.153350</pub-id><pub-id pub-id-type="pmid">33002827</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciel</surname><given-names>RAP</given-names></name><name><surname>Cunha</surname><given-names>RS</given-names></name><name><surname>Busato</surname><given-names>V</given-names></name><name><surname>Franco</surname><given-names>CRC</given-names></name><name><surname>Gregório</surname><given-names>PC</given-names></name><name><surname>Dolenga</surname><given-names>CJR</given-names></name><name><surname>Nakao</surname><given-names>LS</given-names></name><name><surname>Massy</surname><given-names>ZA</given-names></name><name><surname>Boullier</surname><given-names>A</given-names></name><name><surname>Pecoits-Filho</surname><given-names>R</given-names></name><name><surname>Stinghen</surname><given-names>AEM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions</article-title><source>Toxins</source><volume>10</volume><elocation-id>E404</elocation-id><pub-id pub-id-type="doi">10.3390/toxins10100404</pub-id><pub-id pub-id-type="pmid">30301260</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matarese</surname><given-names>A</given-names></name><name><surname>Gambardella</surname><given-names>J</given-names></name><name><surname>Sardu</surname><given-names>C</given-names></name><name><surname>Santulli</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19</article-title><source>Biomedicines</source><volume>8</volume><elocation-id>462</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines8110462</pub-id><pub-id pub-id-type="pmid">33143053</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina-Leyte</surname><given-names>DJ</given-names></name><name><surname>Domínguez-Pérez</surname><given-names>M</given-names></name><name><surname>Mercado</surname><given-names>I</given-names></name><name><surname>Villarreal-Molina</surname><given-names>MT</given-names></name><name><surname>Jacobo-Albavera</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Use of Human Umbilical Vein Endothelial Cells (HUVEC) as a Model to Study Cardiovascular Disease: A Review</article-title><source>Applied Sciences</source><volume>10</volume><elocation-id>938</elocation-id><pub-id pub-id-type="doi">10.3390/app10030938</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>B</given-names></name><name><surname>Silverstein</surname><given-names>A</given-names></name><name><surname>Flores</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name><name><surname>Kumagai</surname><given-names>H</given-names></name><name><surname>Mehta</surname><given-names>HH</given-names></name><name><surname>Yen</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-79552-z</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>LT</given-names></name><name><surname>Zhuang</surname><given-names>ZW</given-names></name><name><surname>Zhang</surname><given-names>ZW</given-names></name><name><surname>Moodie</surname><given-names>KL</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Stan</surname><given-names>RV</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The FGF system has a key role in regulating vascular integrity</article-title><source>The Journal of Clinical Investigation</source><volume>118</volume><fpage>3355</fpage><lpage>3366</lpage><pub-id pub-id-type="doi">10.1172/JCI35298</pub-id><pub-id pub-id-type="pmid">18776942</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nägele</surname><given-names>MP</given-names></name><name><surname>Haubner</surname><given-names>B</given-names></name><name><surname>Tanner</surname><given-names>FC</given-names></name><name><surname>Ruschitzka</surname><given-names>F</given-names></name><name><surname>Flammer</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endothelial dysfunction in COVID-19: Current findings and therapeutic implications</article-title><source>Atherosclerosis</source><volume>314</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2020.10.014</pub-id><pub-id pub-id-type="pmid">33161318</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakato</surname><given-names>R</given-names></name><name><surname>Wada</surname><given-names>Y</given-names></name><name><surname>Nakaki</surname><given-names>R</given-names></name><name><surname>Nagae</surname><given-names>G</given-names></name><name><surname>Katou</surname><given-names>Y</given-names></name><name><surname>Tsutsumi</surname><given-names>S</given-names></name><name><surname>Nakajima</surname><given-names>N</given-names></name><name><surname>Fukuhara</surname><given-names>H</given-names></name><name><surname>Iguchi</surname><given-names>A</given-names></name><name><surname>Kohro</surname><given-names>T</given-names></name><name><surname>Kanki</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Izumi-Taguchi</surname><given-names>A</given-names></name><name><surname>Osato</surname><given-names>N</given-names></name><name><surname>Tatsuno</surname><given-names>K</given-names></name><name><surname>Kamio</surname><given-names>A</given-names></name><name><surname>Hayashi-Takanaka</surname><given-names>Y</given-names></name><name><surname>Wada</surname><given-names>H</given-names></name><name><surname>Ohta</surname><given-names>S</given-names></name><name><surname>Aikawa</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>McGee</surname><given-names>RC</given-names></name><name><surname>Heppner</surname><given-names>KW</given-names></name><name><surname>Kawakatsu</surname><given-names>T</given-names></name><name><surname>Genno</surname><given-names>M</given-names></name><name><surname>Yanase</surname><given-names>H</given-names></name><name><surname>Kume</surname><given-names>H</given-names></name><name><surname>Senbonmatsu</surname><given-names>T</given-names></name><name><surname>Homma</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>S</given-names></name><name><surname>Mitsuyama</surname><given-names>T</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Shirahige</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive epigenome characterization reveals diverse transcriptional regulation across human vascular endothelial cells</article-title><source>Epigenetics &amp; Chromatin</source><volume>12</volume><elocation-id>e0319-0</elocation-id><pub-id pub-id-type="doi">10.1186/s13072-019-0319-0</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nascimento Conde</surname><given-names>J</given-names></name><name><surname>Schutt</surname><given-names>WR</given-names></name><name><surname>Gorbunova</surname><given-names>EE</given-names></name><name><surname>Mackow</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses</article-title><source>MBio</source><volume>11</volume><elocation-id>e03185-20</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.03185-20</pub-id><pub-id pub-id-type="pmid">33310781</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orologas-Stavrou</surname><given-names>N</given-names></name><name><surname>Politou</surname><given-names>M</given-names></name><name><surname>Rousakis</surname><given-names>P</given-names></name><name><surname>Kostopoulos</surname><given-names>IV</given-names></name><name><surname>Ntanasis-Stathopoulos</surname><given-names>I</given-names></name><name><surname>Jahaj</surname><given-names>E</given-names></name><name><surname>Tsiligkeridou</surname><given-names>E</given-names></name><name><surname>Gavriatopoulou</surname><given-names>M</given-names></name><name><surname>Kastritis</surname><given-names>E</given-names></name><name><surname>Kotanidou</surname><given-names>A</given-names></name><name><surname>Dimopoulos</surname><given-names>MA</given-names></name><name><surname>Tsitsilonis</surname><given-names>OE</given-names></name><name><surname>Terpos</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection</article-title><source>Viruses</source><volume>13</volume><elocation-id>E26</elocation-id><pub-id pub-id-type="doi">10.3390/v13010026</pub-id><pub-id pub-id-type="pmid">33375675</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Dan</surname><given-names>K</given-names></name><name><surname>Seong</surname><given-names>MW</given-names></name><name><surname>Han</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>22418</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-80120-8</pub-id><pub-id pub-id-type="pmid">33376242</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Lei</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens</article-title><source>Journal of Medical Virology</source><volume>92</volume><fpage>1676</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1002/jmv.25936</pub-id><pub-id pub-id-type="pmid">32330305</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Q</given-names></name><name><surname>Peng</surname><given-names>R</given-names></name><name><surname>Yuan</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>Z</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>GF</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107774</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107774</pub-id><pub-id pub-id-type="pmid">32531208</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peruzzi</surname><given-names>B</given-names></name><name><surname>Bencini</surname><given-names>S</given-names></name><name><surname>Capone</surname><given-names>M</given-names></name><name><surname>Mazzoni</surname><given-names>A</given-names></name><name><surname>Maggi</surname><given-names>L</given-names></name><name><surname>Salvati</surname><given-names>L</given-names></name><name><surname>Vanni</surname><given-names>A</given-names></name><name><surname>Orazzini</surname><given-names>C</given-names></name><name><surname>Nozzoli</surname><given-names>C</given-names></name><name><surname>Morettini</surname><given-names>A</given-names></name><name><surname>Poggesi</surname><given-names>L</given-names></name><name><surname>Pieralli</surname><given-names>F</given-names></name><name><surname>Peris</surname><given-names>A</given-names></name><name><surname>Bartoloni</surname><given-names>A</given-names></name><name><surname>Vannucchi</surname><given-names>AM</given-names></name><name><surname>Liotta</surname><given-names>F</given-names></name><name><surname>Caporale</surname><given-names>R</given-names></name><name><surname>Cosmi</surname><given-names>L</given-names></name><name><surname>Annunziato</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection</article-title><source>Immunology</source><volume>161</volume><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1111/imm.13254</pub-id><pub-id pub-id-type="pmid">32870529</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>MT</given-names></name><name><surname>Ferreira Melo</surname><given-names>FU</given-names></name><name><surname>Malta</surname><given-names>TM</given-names></name><name><surname>Rodrigues</surname><given-names>ES</given-names></name><name><surname>Plaça</surname><given-names>JR</given-names></name><name><surname>Silva</surname><given-names>WA</given-names></name><name><surname>Panepucci</surname><given-names>RA</given-names></name><name><surname>Covas</surname><given-names>DT</given-names></name><name><surname>de Oliveira Rodrigues</surname><given-names>C</given-names></name><name><surname>Kashima</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endothelial cells from different anatomical origin have distinct responses during SNAIL/TGF-β2-mediated endothelial-mesenchymal transition</article-title><source>American Journal of Translational Research</source><volume>10</volume><fpage>4065</fpage><lpage>4081</lpage><pub-id pub-id-type="pmid">30662651</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pober</surname><given-names>JS</given-names></name><name><surname>Sessa</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Evolving functions of endothelial cells in inflammation</article-title><source>Nature Reviews. Immunology</source><volume>7</volume><fpage>803</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1038/nri2171</pub-id><pub-id pub-id-type="pmid">17893694</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polus</surname><given-names>A</given-names></name><name><surname>Kiec-Wilk</surname><given-names>B</given-names></name><name><surname>Hartwich</surname><given-names>J</given-names></name><name><surname>Balwierz</surname><given-names>A</given-names></name><name><surname>Stachura</surname><given-names>J</given-names></name><name><surname>Dyduch</surname><given-names>G</given-names></name><name><surname>Laidler</surname><given-names>P</given-names></name><name><surname>Zagajewski</surname><given-names>J</given-names></name><name><surname>Langman</surname><given-names>T</given-names></name><name><surname>Schmitz</surname><given-names>G</given-names></name><name><surname>Goralczyk</surname><given-names>R</given-names></name><name><surname>Wertz</surname><given-names>K</given-names></name><name><surname>Riss</surname><given-names>G</given-names></name><name><surname>Keijer</surname><given-names>J</given-names></name><name><surname>Dembinska-Kiec</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The chemotactic activity of beta-carotene in endothelial cell progenitors and human umbilical vein endothelial cells: A microarray analysis</article-title><source>Experimental and Clinical Cardiology</source><volume>11</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">18651047</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pons</surname><given-names>S</given-names></name><name><surname>Fodil</surname><given-names>S</given-names></name><name><surname>Azoulay</surname><given-names>E</given-names></name><name><surname>Zafrani</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection</article-title><source>Critical Care</source><volume>24</volume><elocation-id>353</elocation-id><pub-id pub-id-type="doi">10.1186/s13054-020-03062-7</pub-id><pub-id pub-id-type="pmid">32546188</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potus</surname><given-names>F</given-names></name><name><surname>Mai</surname><given-names>V</given-names></name><name><surname>Lebret</surname><given-names>M</given-names></name><name><surname>Malenfant</surname><given-names>S</given-names></name><name><surname>Breton-Gagnon</surname><given-names>E</given-names></name><name><surname>Lajoie</surname><given-names>AC</given-names></name><name><surname>Boucherat</surname><given-names>O</given-names></name><name><surname>Bonnet</surname><given-names>S</given-names></name><name><surname>Provencher</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Novel insights on the pulmonary vascular consequences of COVID-19</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>319</volume><fpage>L277</fpage><lpage>L288</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00195.2020</pub-id><pub-id pub-id-type="pmid">32551862</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Procko</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Sequence of Human ACE2 Is Suboptimal for Binding the S Spike Protein of SARS Coronavirus 2</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.03.16.994236</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pum</surname><given-names>A</given-names></name><name><surname>Ennemoser</surname><given-names>M</given-names></name><name><surname>Adage</surname><given-names>T</given-names></name><name><surname>Kungl</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm</article-title><source>Biomolecules</source><volume>11</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.3390/biom11010091</pub-id><pub-id pub-id-type="pmid">33445810</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietveld</surname><given-names>IM</given-names></name><name><surname>Lijfering</surname><given-names>WM</given-names></name><name><surname>le Cessie</surname><given-names>S</given-names></name><name><surname>Bos</surname><given-names>MHA</given-names></name><name><surname>Rosendaal</surname><given-names>FR</given-names></name><name><surname>Reitsma</surname><given-names>PH</given-names></name><name><surname>Cannegieter</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>17</volume><fpage>99</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1111/jth.14343</pub-id><pub-id pub-id-type="pmid">30471183</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>M</given-names></name><name><surname>Ruggiero</surname><given-names>A</given-names></name><name><surname>Squeglia</surname><given-names>F</given-names></name><name><surname>Maga</surname><given-names>G</given-names></name><name><surname>Berisio</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping</article-title><source>Cells</source><volume>9</volume><elocation-id>1267</elocation-id><pub-id pub-id-type="doi">10.3390/cells9051267</pub-id><pub-id pub-id-type="pmid">32443810</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandig</surname><given-names>M</given-names></name><name><surname>Korvemaker</surname><given-names>ML</given-names></name><name><surname>Ionescu</surname><given-names>CV</given-names></name><name><surname>Negrou</surname><given-names>E</given-names></name><name><surname>Rogers</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Transendothelial migration of monocytes in rat aorta: distribution of F-actin, alpha-catnin, LFA-1, and PECAM-1</article-title><source>Biotechnic &amp; Histochemistry</source><volume>74</volume><fpage>276</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.3109/10520299909034666</pub-id><pub-id pub-id-type="pmid">10768807</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>J-Y</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqi</surname><given-names>HK</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 and vascular disease</article-title><source>EBioMedicine</source><volume>58</volume><elocation-id>102966</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102966</pub-id><pub-id pub-id-type="pmid">32829782</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>B</given-names></name><name><surname>Kolli</surname><given-names>AR</given-names></name><name><surname>Esch</surname><given-names>MB</given-names></name><name><surname>Abaci</surname><given-names>HE</given-names></name><name><surname>Shuler</surname><given-names>ML</given-names></name><name><surname>Hickman</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TEER measurement techniques for in vitro barrier model systems</article-title><source>Journal of Laboratory Automation</source><volume>20</volume><fpage>107</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1177/2211068214561025</pub-id><pub-id pub-id-type="pmid">25586998</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teuwen</surname><given-names>LA</given-names></name><name><surname>Geldhof</surname><given-names>V</given-names></name><name><surname>Pasut</surname><given-names>A</given-names></name><name><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19: the vasculature unleashed</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>389</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0343-0</pub-id><pub-id pub-id-type="pmid">32439870</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vailhé</surname><given-names>B</given-names></name><name><surname>Vittet</surname><given-names>D</given-names></name><name><surname>Feige</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>vitro models of vasculogenesis and angiogenesis</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>81</volume><fpage>439</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3780252</pub-id><pub-id pub-id-type="pmid">11304563</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>Z</given-names></name><name><surname>Flammer</surname><given-names>AJ</given-names></name><name><surname>Steiger</surname><given-names>P</given-names></name><name><surname>Haberecker</surname><given-names>M</given-names></name><name><surname>Andermatt</surname><given-names>R</given-names></name><name><surname>Zinkernagel</surname><given-names>AS</given-names></name><name><surname>Mehra</surname><given-names>MR</given-names></name><name><surname>Schuepbach</surname><given-names>RA</given-names></name><name><surname>Ruschitzka</surname><given-names>F</given-names></name><name><surname>Moch</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endothelial cell infection and endotheliitis in COVID-19</article-title><source>Lancet</source><volume>395</volume><fpage>1417</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30937-5</pub-id><pub-id pub-id-type="pmid">32325026</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vestweber</surname><given-names>D</given-names></name><name><surname>Winderlich</surname><given-names>M</given-names></name><name><surname>Cagna</surname><given-names>G</given-names></name><name><surname>Nottebaum</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player</article-title><source>Trends in Cell Biology</source><volume>19</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2008.10.001</pub-id><pub-id pub-id-type="pmid">19010680</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Chiang</surname><given-names>ET</given-names></name><name><surname>Simmons</surname><given-names>JT</given-names></name><name><surname>Garcia</surname><given-names>JGN</given-names></name><name><surname>Dudek</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl</article-title><source>The European Respiratory Journal</source><volume>38</volume><fpage>78</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1183/09031936.00047810</pub-id><pub-id pub-id-type="pmid">21071472</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Montaner</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts</article-title><source>Journal of Leukocyte Biology</source><volume>108</volume><fpage>17</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1002/JLB.3COVR0520-272R</pub-id><pub-id pub-id-type="pmid">32534467</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Detection of SARS-CoV-2 in Different Types of Clinical Specimens</article-title><source>JAMA</source><volume>323</volume><fpage>1843</fpage><lpage>1844</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.3786</pub-id><pub-id pub-id-type="pmid">32159775</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wazny</surname><given-names>V</given-names></name><name><surname>Siau</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>KX</given-names></name><name><surname>Cheung</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Vascular underpinning of COVID-19</article-title><source>Open Biology</source><volume>10</volume><elocation-id>200208</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.200208</pub-id><pub-id pub-id-type="pmid">32847471</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessells</surname><given-names>H</given-names></name><name><surname>Sullivan</surname><given-names>CJ</given-names></name><name><surname>Tsubota</surname><given-names>Y</given-names></name><name><surname>Engel</surname><given-names>KL</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Olson</surname><given-names>NE</given-names></name><name><surname>Thorner</surname><given-names>D</given-names></name><name><surname>Chitaley</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Transcriptional profiling of human cavernosal endothelial cells reveals distinctive cell adhesion phenotype and role for claudin 11 in vascular barrier function</article-title><source>Physiological Genomics</source><volume>39</volume><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1152/physiolgenomics.90354.2008</pub-id><pub-id pub-id-type="pmid">19622796</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Yao</surname><given-names>Q</given-names></name><name><surname>Lumsden</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Characterization of two populations of human coronary artery endothelial cells(1</article-title><source>The Journal of Surgical Research</source><volume>118</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2004.01.009</pub-id><pub-id pub-id-type="pmid">15093715</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JC</given-names></name><name><surname>Yan</surname><given-names>HC</given-names></name><name><surname>Chen</surname><given-names>WT</given-names></name><name><surname>Chen</surname><given-names>WH</given-names></name><name><surname>Wang</surname><given-names>CJ</given-names></name><name><surname>Chi</surname><given-names>YC</given-names></name><name><surname>Kao</surname><given-names>WY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC</article-title><source>Experimental Cell Research</source><volume>314</volume><fpage>421</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2007.10.002</pub-id><pub-id pub-id-type="pmid">18164704</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J-D</given-names></name><name><surname>Tang</surname><given-names>R-N</given-names></name><name><surname>Crowley</surname><given-names>SD</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Lv</surname><given-names>L-L</given-names></name><name><surname>Ma</surname><given-names>K-L</given-names></name><name><surname>Liu</surname><given-names>B-C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Elevated PTH induces endothelial-to-chondrogenic transition in aortic endothelial cells</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>312</volume><fpage>F436</fpage><lpage>F444</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00210.2016</pub-id><pub-id pub-id-type="pmid">27582099</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Shelite</surname><given-names>TR</given-names></name><name><surname>Chang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Bukreyev</surname><given-names>A</given-names></name><name><surname>Soong</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Ksiazek</surname><given-names>T</given-names></name><name><surname>Gaitas</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>SL</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Laposata</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>TB</given-names></name><name><surname>Gong</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>EPAC Regulates von Willebrand Factor Secretion from Endothelial Cells in a PI3K/ENOS-Dependent Manner during Inflammation</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.09.04.282806</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Petitjean</surname><given-names>SJL</given-names></name><name><surname>Koehler</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Dumitru</surname><given-names>AC</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Derclaye</surname><given-names>S</given-names></name><name><surname>Vincent</surname><given-names>SP</given-names></name><name><surname>Soumillion</surname><given-names>P</given-names></name><name><surname>Alsteens</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4541</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18319-6</pub-id><pub-id pub-id-type="pmid">32917884</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Le Bras</surname><given-names>A</given-names></name><name><surname>Sacharidou</surname><given-names>A</given-names></name><name><surname>Itagaki</surname><given-names>K</given-names></name><name><surname>Zhan</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name><name><surname>Carman</surname><given-names>CV</given-names></name><name><surname>Davis</surname><given-names>GE</given-names></name><name><surname>Aird</surname><given-names>WC</given-names></name><name><surname>Oettgen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>6582</fpage><lpage>6591</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.300236</pub-id><pub-id pub-id-type="pmid">22235125</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zebda</surname><given-names>N</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Gawlak</surname><given-names>G</given-names></name><name><surname>Higginbotham</surname><given-names>K</given-names></name><name><surname>Reynolds</surname><given-names>AB</given-names></name><name><surname>Birukova</surname><given-names>AA</given-names></name><name><surname>Birukov</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>teraction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>18290</fpage><lpage>18299</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.432757</pub-id><pub-id pub-id-type="pmid">23653363</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69314.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mangoni</surname><given-names>Arduino A</given-names></name><role>Reviewing Editor</role><aff><institution>Flinders Medical Centre</institution><country>Australia</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Pasqualini</surname><given-names>Francesco</given-names></name><role>Reviewer</role><aff><institution/><country>Italy</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Vatine</surname><given-names>Gad</given-names></name><role>Reviewer</role><aff><institution>Ben Gurion University</institution></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In their manuscript, Rauti, Shahoha et al., sought to identify the effect of SARS-CoV2 proteins on endothelial functions. They systematically transduced HUVECs cultured on a transwell with various SARS-CoV2 proteins from three classes including non-structural and accessory proteins. They have assessed the effect of separate overexpression of each of 26 proteins, and tested their effect on 26 of the 29 proteins in the SARS-CoV2 genome. The authors found that overexpression of some proteins had stronger effect on the barrier functions on HUVECs compared to other proteins. Using a PPI network analysis, they predicted endothelial proteins that may be affected by the viral protein, which may potentially mediate this effect. The findings add to the understanding how SARS-CoV2 may negatively affect endothelial cell homeostasis, which may contribute to vascular and thrombotic complications associated with a severe course of the disease in patients diagnosed with COVID-19.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Effect of SARS-CoV-2 proteins on vascular permeability&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Matthias Barton as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Francesco Pasqualini (Reviewer #1); Gad Vatine (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors provide putative virus-host protein-protein interaction networks that could be very valuable for future translational efforts. However, it would be best to validate at least one of those on the HUVECS/TEER assay. Would it be possible to rescue endothelial dysfunction acting (pharmacologically or genetically) on any of the identified host proteins downstream of the viral protein?</p><p>2) The authors provide virus-host protein interaction networks for endothelial cells of various organs. This, again, could be a very valuable target identification exercise for future pharmacological work but it would need to be validated. Can the rescue experiment discussed above be replicated using the TEER assay, organ-specific endothelial cells, and pharmacological or genetic means to normalize the expression of host proteins downstream of the viral protein in the organ-specific PPI network?</p><p>3) More validation data will help but it might be worth revising the discussion as well, especially as the new validation data may make parts of the current Discussion redundant.</p><p>4) Page 4, line 98 – &quot;Permeability was measured via trans-epithelial-endothelial 99 electrical resistance (TEER), a standard method that identifies changes in impedance values&quot;. TEER is a method for assessing barrier functions, and it is related to permeability, but permeability should be measured by fluorescent paracellular assays. These should be separated.</p><p>5) While significant, the changes in TEER are very small. The authors should specify in the figure legend, which statistical tests have been applied, and should specify that they have accounted for multiple comparison tests. Also, changes in TEER over time should be showed.</p><p>6) In order to avoid conclusions that may be linked to direct regulation on CD31, changes in protein expression should be made on additional proteins that are related to tight junctions such as ZO1.</p><p>7) Overall, all experiments were performed on a single source of in vitro human endothelial cells. The authors should discuss possibilities for additional endothelial cell models that could potentially be used for future studies, and discuss the advantages and disadvantages of HUVECs.</p><p>8) The authors develop a mathematic model to identify interactions of the SARS-CoV2 proteins with tissue targets. While this represents a novel an important approach, authors should show a validation of the model to prove its validity. If this cannot be applied in the HUVECs system, the authors should explain its limitations and at least discuss what possible models could be used to validate it in the future.</p><p>9) Since the authors identify WNT signaling as a key pathway, the authors cold consider manipulating the WNT pathway in HUVECs cells as a possible treatment for rescuing this effect.<italic>Reviewer #1:</italic></p><p>The hypothesis of the authors is that non-spike SARS-CoV-2 proteins are responsible for the increased vascular permeability observed in COVID-19 patients during the primary infection and, possibly, long after it is resolved. To identify which protein(s) might be responsible, they used lentiviruses to express 26/29 SARS-CoV-2 proteins in human endothelial cells (HUVECS) using trans-epithelial-endothelial electrical resistance (TEER), a standard assessment of vascular permeability. Among the viral proteins that directly increased vascular permeability, the authors identified a subset (nsp2,29 nsp5_c145a (catalytic dead mutant of nsp5) and nsp7) capable of inducing broader endothelial dysfunction (downregulated CD31 and upregulated VWF and IL-6). Finally, they used protein-protein interaction analysis to semi-quantitatively speculate how these viral proteins may lead to endothelial dysfunction and increased vascular permeability in various human organs.</p><p>Strengths</p><p>The use of a library of LV to test each individual SARS-CoV-2 protein is interesting. While hard to use combinatorially, being able to isolate the influence of each protein will be important in understanding the secondary effect of COVID-19 infections (e.g., long COVID).</p><p>The combination of imaging and TEER to screen how each viral protein changes endothelial structure, function, or both.</p><p>The use of bio-informatics to relate the raw findings from the cellular assay with broader translational implications, namely through which pathways may viral protein end up affecting vascular permeability and endothelial dysfunction.</p><p>Weaknesses</p><p>I feel like the paper is missing two key additional validations.</p><p>First, the authors provide putative virus-host protein-protein interaction networks that could be very valuable for future translational efforts. However, it would be best to validate at least one of those on the HUVECS/TEER assay. Would it be possible to rescue endothelial dysfunction acting (pharmacologically or genetically) on any of the identified host proteins downstream of the viral protein?</p><p>Second, the authors provide virus-host protein interaction networks for endothelial cells of various organs. This, again, could be a very valuable target identification exercise for future pharmacological work but it would need to be validated. Can the rescue experiment discussed above be replicated using the TEER assay, organ-specific endothelial cells, and pharmacological or genetic means to normalize the expression of host proteins downstream of the viral protein in the organ-specific PPI network?<italic>Reviewer #2:</italic></p><p>In their manuscript, Rauti, Shahoha et al., sought to identify the effect of SARS-CoV2 proteins on endothelial functions. They systematically transduced HUVECs cultured on a transwell with various SARS-CoV2 proteins from three classes including non-structural and accessory proteins. They have assessed the effect of separate overexpression of each of 26 proteins, and tested their effect on 26 of the 29 proteins in the SARS-CoV2 genome. The authors found that overexpression of some proteins had stronger effect on the barrier functions on HUVECs compared to other proteins. Using a PPI network analysis, they predicted endothelial proteins that may be affected by the viral protein, which may potentially mediate this effect.</p><p>The novelty of the study is in directly testing the response of endothelial cells to the virus. Previous reports focused on the phenotype in patients, or using animal models without specifying the exact proteins involved in the dysfunction. Gaining knowledge on the molecular mechanisms, especially the protein-protein interaction pathways that lead to tissue dysfunction, may help understanding the pandemic a potentially help develop treatments.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69314.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors provide putative virus-host protein-protein interaction networks that could be very valuable for future translational efforts. However, it would be best to validate at least one of those on the HUVECS/TEER assay. Would it be possible to rescue endothelial dysfunction acting (pharmacologically or genetically) on any of the identified host proteins downstream of the viral protein?</p></disp-quote><p>We would like to thank the referee for his suggestion. We agree that it is important to show the validity of the model before using it on other proteins. Following the referee’s suggestion, we have performed a series of experiments to validate the model (new Figure 5). Our new data present high correlation between the PPI prediction and the experimental data.</p><disp-quote content-type="editor-comment"><p>2) The authors provide virus-host protein interaction networks for endothelial cells of various organs. This, again, could be a very valuable target identification exercise for future pharmacological work but it would need to be validated. Can the rescue experiment discussed above be replicated using the TEER assay, organ-specific endothelial cells, and pharmacological or genetic means to normalize the expression of host proteins downstream of the viral protein in the organ-specific PPI network?</p></disp-quote><p>Following the referee’s suggestion to examine different organ-specific endothelial cells, we have made a unique comparison of the expression level of the different endothelial proteins in 9 different vascular endothelial cell types (see new Table 2).</p><p>Although we assumed that most proteins will be detected in these lines, we were surprised to learn that in some cell lines, like the HAoEC, all cadherin proteins (Cadherin 2-5) do not express while in others Catenin d is not expressed while in other most ZO proteins are missing. We were surprised to learn that such a comparison was never published, making this publication also unique in that way.</p><p>After we validated the PPI network, we used it to examine how the specific SARS-Cov-2 proteins affect the organ-specific endothelial cells (for 9 organ-specific vascular endothelial cells). Our results presented in new Figure 6 predict that not only the HUVEC permeability properties are impaired by the SARSCov-2 proteins, but other vascular endothelial cells are strongly affected as well. Interestingly, we see that different endothelial cells response differently to SARS-Cov-2, mainly due to the different expression of the tight junctions proteins.</p><disp-quote content-type="editor-comment"><p>3) More validation data will help but it might be worth revising the discussion as well, especially as the new validation data may make parts of the current Discussion redundant.</p></disp-quote><p>The discussion was revised according to the new validation.</p><disp-quote content-type="editor-comment"><p>4) Page 4, line 98 – &quot;Permeability was measured via trans-epithelial-endothelial 99 electrical resistance (TEER), a standard method that identifies changes in impedance values&quot;. TEER is a method for assessing barrier functions, and it is related to permeability, but permeability should be measured by fluorescent paracellular assays. These should be separated.</p></disp-quote><p>We thank the author for this comment. The text was revised to better clarify this point.</p><disp-quote content-type="editor-comment"><p>5) While significant, the changes in TEER are very small. The authors should specify in the figure legend, which statistical tests have been applied, and should specify that they have accounted for multiple comparison tests. Also, changes in TEER over time should be showed.</p></disp-quote><p>In this work we used ANOVA-multiple comparison test to account for the multiple comparison among different groups. This was described in the method section and per the reviewer request, it was also added to the figure legend.</p><p>The TEER dynamic is highly dependent on the cell density, age, and condition. Per the reviewer request, we added the TEER values of the cells in multiple time points (before the infection, 3 and 4 days after the infection (new Figure S1)).</p><disp-quote content-type="editor-comment"><p>6) In order to avoid conclusions that may be linked to direct regulation on CD31, changes in protein expression should be made on additional proteins that are related to tight junctions such as ZO1.</p></disp-quote><p>We would like to thank the referee for this comment. We have performed additional set of experiments examining also the effect on ZO1 (and other 3 proteins, B-Catenin, Cadherine 5 and Occludin). The new data, now in new Figure 5, show that the viral proteins that showed a significant decrease in the TEER values as well as in the CD31 intensity, significant affect the expression of these other tight-junctions proteins.</p><disp-quote content-type="editor-comment"><p>7) Overall, all experiments were performed on a single source of in vitro human endothelial cells. The authors should discuss possibilities for additional endothelial cell models that could potentially be used for future studies, and discuss the advantages and disadvantages of HUVECs.</p></disp-quote><p>As we discussed in “point 2”, we created a table which compares 9 organ-specific endothelial cells. We added the results as Table 2 and new Figure 6<bold>.</bold></p><p>We also revised the text accordingly.</p><disp-quote content-type="editor-comment"><p>8) The authors develop a mathematic model to identify interactions of the SARS-CoV2 proteins with tissue targets. While this represents a novel an important approach, authors should show a validation of the model to prove its validity. If this cannot be applied in the HUVECs system, the authors should explain its limitations and at least discuss what possible models could be used to validate it in the future.</p></disp-quote><p>As we discussed in “point 2”, we created a table which compares 9 organ-specific endothelial cells. We added the results as Table 2 and new Figure 6<bold>.</bold></p><p>We also revised the text accordingly.</p><disp-quote content-type="editor-comment"><p>9) Since the authors identify WNT signaling as a key pathway, the authors cold consider manipulating the WNT pathway in HUVECs cells as a possible treatment for rescuing this effect.</p></disp-quote><p>WNT was suggested as a relevant pathway due to its known contribution to BBB impairment in multiple sclerosis and other pathologies (Jung, Y., et al. ACS Infect. Dis. (2020); Lengfeld, J. E.,et al. Proc Natl Acad Sci (2017)). In addition, the ßcatenin is part of the WNT signaling, and we showed the validation of its effect by the SARS-Cov-2, i.e. decrease in expression caused by the virus infection. But since it is not the main claim of the paper, (the contribution of the WNT to the BBB impairment due to the SARS-Cov-2) we removed this point from the discussion. Manipulation of the WNT signaling pathway is beyond the scope of this paper.</p></body></sub-article></article>